[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,931,975,1006,1127,1202,1275,1307,1378],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":786,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":114,"primaryUrl":787,"fullTextUrl":26,"authors":788,"publicationType":747,"publisherRelationship":918,"citationCount":26,"citationInfo":26,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4c0e735f-8507-4d39-8799-f4528700f95e","2024-01-01T14:14:24.354+00:00","2024-12-12T20:50:29.890+00:00",[],"Epidemiolog%C3%ADa-del-c%C3%A1ncer-de-mama",{"references":780,"title":782,"doi":784},{"VOID":781},"Defossez, 2019\nCowppli-Bony, 2019, Descriptive epidemiology of cancer in metropolitan France: incidence, survival and prevalence, Bull Cancer, 106, 617, 10.1016\u002Fj.bulcan.2018.11.016\nCronin, 2018, Annual report to the Nation on the status of cancer, part I: National cancer statistics, Cancer, 124, 2785, 10.1002\u002Fcncr.31551\nColonna, 2015\nOrsini, 2016, Individual socioeconomic status and breast cancer diagnostic stages: a French case-control study, Eur J Public Health, 26, 445, 10.1093\u002Feurpub\u002Fckv233\nTron, 2019, Socioeconomic environment and disparities in cancer survival for 19 solid tumor sites: an analysis of the French Network of Cancer Registries (FRANCIM) data, Int J Cancer, 144, 1262, 10.1002\u002Fijc.31951\nAllemani, 2018, Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries, Lancet, 391, 1023, 10.1016\u002FS0140-6736(17)33326-3\nColeman, 2003, EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century, Ann Oncol, 14, v128, 10.1093\u002Fannonc\u002Fmdg756\nSant, 2003, Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe, Int J Cancer, 106, 416, 10.1002\u002Fijc.11226\nBerry, 2005, Effect of screening and adjuvant therapy on mortality from breast cancer, N Engl J Med, 353, 1784, 10.1056\u002FNEJMoa050518\nKalager, 2010, Effect of screening mammography on breast-cancer mortality in Norway, N Engl J Med, 363, 1203, 10.1056\u002FNEJMoa1000727\nFerlay, 2018, Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018, Eur J Cancer, 103, 356, 10.1016\u002Fj.ejca.2018.07.005\nBray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 68, 394, 10.3322\u002Fcaac.21492\nStanford, 1995, Breast cancer incidence in Asian migrants to the United States and their descendants, Epidemiology, 6, 181, 10.1097\u002F00001648-199503000-00017\nJohn, 2005, Migration history, acculturation, and breast cancer risk in Hispanic women, Cancer Epidemiol Biomark Prev, 14, 2905, 10.1158\u002F1055-9965.EPI-05-0483\nParkin, 1990, Cancer in Jewish migrants to Israel, Int J Cancer, 45, 614, 10.1002\u002Fijc.2910450407\nChavez-Macgregor, 2013, Male breast cancer according to tumor subtype and race: a population-based study, Cancer, 119, 1611, 10.1002\u002Fcncr.27905\nTulinius, 1992, Epidemiology of breast cancer in families in Iceland, J Med Genet, 29, 158, 10.1136\u002Fjmg.29.3.158\nXue, 2007, Intrauterine factors and risk of breast cancer: a systematic review and meta-analysis of current evidence, Lancet Oncol, 8, 1088, 10.1016\u002FS1470-2045(07)70377-7\nMichels, 1996, Birthweight as a risk factor for breast cancer, Lancet, 348, 1542, 10.1016\u002FS0140-6736(96)03102-9\nAhlgren, 2004, Growth patterns and the risk of breast cancer in women, N Engl J Med, 351, 1619, 10.1056\u002FNEJMoa040576\nMichels, 2006, Role of birthweight in the etiology of breast cancer, Int J Cancer, 119, 2007, 10.1002\u002Fijc.22004\nPark, 2008, Intrauterine environments and breast cancer risk: meta-analysis and systematic review, Breast Cancer Res, 10, R8, 10.1186\u002Fbcr1850\nEkbom, 1997, Intrauterine environment and breast cancer risk in women: a population-based study, J Natl Cancer Inst, 89, 71, 10.1093\u002Fjnci\u002F89.1.71\nCnattingius, 2005, Pregnancy characteristics and maternal risk of breast cancer, JAMA, 294, 2474, 10.1001\u002Fjama.294.19.2474\nDenholm, 2016, Pre-natal exposures and breast tissue composition: findings from a British pre-birth cohort of young women and a systematic review, Breast Cancer Res, 18, 102, 10.1186\u002Fs13058-016-0751-z\nCohn, 2015, DDT exposure in utero and breast cancer, J Clin Endocrinol Metab, 100, 2865, 10.1210\u002Fjc.2015-1841\nKvåle, 1988, Menstrual factors and breast cancer risk, Cancer, 62, 1625, 10.1002\u002F1097-0142(19881015)62:8\u003C1625::AID-CNCR2820620828>3.0.CO;2-K\n2012, Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies, Lancet Oncol, 13, 1141, 10.1016\u002FS1470-2045(12)70425-4\nClavel-Chapelon, 2002, European Prospective Investigation into Cancer. Evolution of age at menarche and at onset of regular cycling in a large cohort of French women, Hum Reprod, 17, 228, 10.1093\u002Fhumrep\u002F17.1.228\nKorenman, 1980, Oestrogen window hypothesis of the aetiology of breast cancer, Lancet, 1, 700, 10.1016\u002FS0140-6736(80)92842-1\nMarguglio N. Lower incidence of breast cancer and cancers of the reproduction system among former college athletes compared to non athletes. Soc for gynecologic investigation meeting. In Phoenix (Arizona); p. 20.\nHenderson, 1985, Do regular ovulatory cycles increase breast cancer risk?, Cancer, 56, 1206, 10.1002\u002F1097-0142(19850901)56:5\u003C1206::AID-CNCR2820560541>3.0.CO;2-9\nGarland, 1998, Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women, Am J Epidemiol, 147, 636, 10.1093\u002Foxfordjournals.aje.a009504\nAdami, 1990, Absence of association between reproductive variables and the risk of breast cancer in young women in Sweden and Norway, Br J Cancer, 62, 122, 10.1038\u002Fbjc.1990.242\nClavel-Chapelon, 2002, Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women, Br J Cancer, 86, 723, 10.1038\u002Fsj.bjc.6600124\nClavel-Chapelon, 2002, Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis?, Breast Cancer Res Treat, 72, 107, 10.1023\u002FA:1014891216621\nTrichopoulos, 1972, Menopause and breast cancer risk, J Natl Cancer Inst, 48, 605\nMacMahon, 1970, Age at first birth and breast cancer risk, Bull World Health Organ, 43, 209\n2002, Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease, Lancet, 360, 187, 10.1016\u002FS0140-6736(02)09454-0\nHarris, 1989, Risk of cancer of the breast after legal abortion during first trimester: a Swedish register study, Br Med J, 299, 1430, 10.1136\u002Fbmj.299.6713.1430\nTavani, 1996, Abortion and breast cancer risk, Int J Cancer, 65, 401, 10.1002\u002F(SICI)1097-0215(19960208)65:4\u003C401::AID-IJC1>3.0.CO;2-0\nMelbye, 1997, Induced abortion and the risk of breast cancer, N Engl J Med, 336, 81, 10.1056\u002FNEJM199701093360201\nBeral, 2004, Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries, Lancet, 363, 1007, 10.1016\u002FS0140-6736(04)15835-2\nReeves, 2006, Breast cancer risk in relation to abortion: results from the EPIC study, Int J Cancer, 119, 1741, 10.1002\u002Fijc.22001\nBruzzi, 1988, Short term increase in risk of breast cancer after full term pregnancy, Br Med J, 297, 1096, 10.1136\u002Fbmj.297.6656.1096\nPathak, 1986, Parity and breast cancer risk: possible effect on age at diagnosis, Int J Cancer, 37, 21, 10.1002\u002Fijc.2910370105\nLambe, 1994, Transient increase in the risk of breast cancer after giving birth, N Engl J Med, 331, 5, 10.1056\u002FNEJM199407073310102\nBernstein, 1985, Estrogen and sex hormone-binding globulin levels in nulliparous and parous women, J Natl Cancer Inst, 74, 741\nKey, 1988, The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer, Eur J Cancer, 24, 29, 10.1016\u002F0277-5379(88)90173-3\nRusso, 1994, Toward a physiological approach to breast cancer prevention, Cancer Epidemiol Biomark Prev, 3, 353\nRusso, 2005, The protective role of pregnancy in breast cancer, Breast Cancer Res, 7, 131, 10.1186\u002Fbcr1029\nFigueroa, 2014, Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology, J Natl Cancer Inst, 106, 10.1093\u002Fjnci\u002Fdju286\nLambertini, 2016, Reproductive behaviors and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis of epidemiological studies, Cancer Treat Rev, 49, 65, 10.1016\u002Fj.ctrv.2016.07.006\nMa, 2017, Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis, Breast Cancer Res, 19, 6, 10.1186\u002Fs13058-016-0799-9\nRitte, 2013, Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study, BMC Cancer, 13, 584, 10.1186\u002F1471-2407-13-584\n1996, Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer, Contraception, 54\nGierisch, 2013, Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review, Cancer Epidemiol Biomark Prev, 22, 1931, 10.1158\u002F1055-9965.EPI-13-0298\nMørch, 2017, Contemporary hormonal contraception and the risk of breast cancer, N Engl J Med, 377, 2228, 10.1056\u002FNEJMoa1700732\nIodice, 2010, Oral contraceptive use and breast or ovarian cancer risk in BRCA1\u002F2 carriers: a meta-analysis, Eur J Cancer, 46, 2275, 10.1016\u002Fj.ejca.2010.04.018\nMoorman, 2013, Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis, J Clin Oncol, 31, 4188, 10.1200\u002FJCO.2013.48.9021\nCibula, 2011, Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis, Expert Rev Anticancer Ther, 11, 1197, 10.1586\u002Fera.11.38\nFriebel, 2014, Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis, J Natl Cancer Inst, 106, 10.1093\u002Fjnci\u002Fdju091\nKotsopoulos, 2014, Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers, Breast Cancer Res Treat, 143, 579, 10.1007\u002Fs10549-013-2823-4\n1997, Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer, Lancet, 350, 1047, 10.1016\u002FS0140-6736(97)08233-0\nRossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001\u002Fjama.288.3.321\nChlebowski, 2003, Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial, JAMA, 289, 3243, 10.1001\u002Fjama.289.24.3243\nAnderson, 2012, Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial, Lancet Oncol, 13, 476, 10.1016\u002FS1470-2045(12)70075-X\nShufelt, 2018, Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study, Menopause, 25, 985, 10.1097\u002FGME.0000000000001115\nFournier, 2005, Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort, Int J Cancer, 114, 448, 10.1002\u002Fijc.20710\nFournier, 2008, Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study, Breast Cancer Res Treat, 107, 103, 10.1007\u002Fs10549-007-9523-x\nEspié, 2006, Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study, Gynecol Endocrinol, 22, 423, 10.1080\u002F09513590600900386\nCordina-Duverger, 2013, Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France, PLoS One, 8, e78016, 10.1371\u002Fjournal.pone.0078016\nColton, 1993, Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up, JAMA, 269, 2096, 10.1001\u002Fjama.1993.03500160066033\nPalmer, 2006, Prenatal diethylstilbestrol exposure and risk of breast cancer, Cancer Epidemiol Biomark Prev, 15, 1509, 10.1158\u002F1055-9965.EPI-06-0109\nPalmer, 2002, Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States), Cancer Causes Control, 13, 753, 10.1023\u002FA:1020254711222\nTroisi, 2007, Cancer risk in women prenatally exposed to diethylstilbestrol, Int J Cancer, 121, 356, 10.1002\u002Fijc.22631\nVerloop, 2010, Cancer risk in DES daughters, Cancer Causes Control, 21, 999, 10.1007\u002Fs10552-010-9526-5\nTournaire, 2015, Cancer risk in women exposed to diethylstilbestrol in utero, Therapie, 70, 433, 10.2515\u002Ftherapie\u002F2015030\nVenn, 1995, Breast and ovarian cancer incidence after infertility and in vitro fertilisation, Lancet, 346, 995, 10.1016\u002FS0140-6736(95)91687-3\nBraga, 1996, Fertility treatment and risk of breast cancer, Hum Reprod, 11, 300, 10.1093\u002FHUMREP\u002F11.2.300\nBrinton, 1989, Cancer risk after evaluation for infertility, Am J Epidemiol, 129, 712, 10.1093\u002Foxfordjournals.aje.a115186\nVenn, 1999, Risk of cancer after use of fertility drugs with in-vitro fertilisation, Lancet, 354, 1586, 10.1016\u002FS0140-6736(99)05203-4\nLerner-Geva, 2006, Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women, Breast Cancer Res Treat, 100, 201, 10.1007\u002Fs10549-006-9238-4\nTerry, 2006, A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer, Arch Intern Med, 166, 2484, 10.1001\u002Farchinte.166.22.2484\nZreik, 2010, Fertility drugs and the risk of breast cancer: a meta-analysis and review, Breast Cancer Res Treat, 124, 13, 10.1007\u002Fs10549-010-1140-4\nGennari, 2015, Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies, Breast Cancer Res Treat, 150, 405, 10.1007\u002Fs10549-015-3328-0\nvan den Belt-Dusebout, 2016, Ovarian stimulation for in vitro fertilization and long-term risk of breast cancer, JAMA, 316, 300, 10.1001\u002Fjama.2016.9389\nSilva I dos, 2008, Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies, PLoS Med, 5, e193, 10.1371\u002Fjournal.pmed.0050193\nUrsin, 1995, A meta-analysis of body mass index and risk of premenopausal breast cancer, Epidemiology, 6, 137, 10.1097\u002F00001648-199503000-00009\nTehard, 2005, Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study, Br J Cancer, 92, 2042, 10.1038\u002Fsj.bjc.6602620\nBaer, 2010, Body fatness at young ages and risk of breast cancer throughout life, Am J Epidemiol, 171, 1183, 10.1093\u002Faje\u002Fkwq045\nPremenopausal Breast Cancer Collaborative Group, 2018, Association of body mass index and age with subsequent breast cancer risk in premenopausal women, JAMA Oncol, 4, e181771, 10.1001\u002Fjamaoncol.2018.1771\nKey, 2003, Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women, J Natl Cancer Inst, 95, 1218, 10.1093\u002Fjnci\u002Fdjg022\nBergström, 2001, Overweight as an avoidable cause of cancer in Europe, Int J Cancer, 91, 421, 10.1002\u002F1097-0215(200002)9999:9999\u003C::AID-IJC1053>3.0.CO;2-T\nYong, 1996, Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, 1979 to 1987-1989, Am J Epidemiol, 143, 985, 10.1093\u002Foxfordjournals.aje.a008681\nMagnusson, 1998, Body size in different periods of life and breast cancer risk in post-menopausal women, Int J Cancer, 76, 29, 10.1002\u002F(SICI)1097-0215(19980330)76:1\u003C29::AID-IJC6>3.0.CO;2-#\nConnolly, 2002, A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer, Nutr Cancer, 44, 127, 10.1207\u002FS15327914NC4402_02\nKirschner, 1990, Androgen-estrogen metabolism in women with upper body versus lower body obesity, J Clin Endocrinol Metab, 70, 473, 10.1210\u002Fjcem-70-2-473\nSchapira, 1991, Obesity, body fat distribution, and sex hormones in breast cancer patients, Cancer, 67, 2215, 10.1002\u002F1097-0142(19910415)67:8\u003C2215::AID-CNCR2820670836>3.0.CO;2-Q\nGammon, 1998, Recreational and occupational physical activities and risk of breast cancer, J Natl Cancer Inst, 90, 100, 10.1093\u002Fjnci\u002F90.2.100\nGammon, 1998, Recreational physical activity and breast cancer risk among women under age 45 years, Am J Epidemiol, 147, 273, 10.1093\u002Foxfordjournals.aje.a009447\nRockhill, 1998, Physical activity and breast cancer risk in a cohort of young women, J Natl Cancer Inst, 90, 1155, 10.1093\u002Fjnci\u002F90.15.1155\nMonninkhof, 2007, Physical activity and breast cancer: a systematic review, Epidemiology, 18, 137, 10.1097\u002F01.ede.0000251167.75581.98\nKyu, 2016, Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013, Br Med J, 354, i3857, 10.1136\u002Fbmj.i3857\nMettlin CJ, Aoki K. Quantitative assessment of fat and calorie as risk factors in mammary carcinogenesis in an experimental model. In: New York: Recent progress in Research on Nutrition and Cancer Proceedings of a workshop Sponsored by the International Union Against Cancer, Japan; 1990. p. 107–17.\nBeth, 1987, Comparison between the effects of dietary fat level and of calorie intake on methylnitrosourea-induced mammary carcinogenesis in female SD rats, Int J Cancer, 39, 737, 10.1002\u002Fijc.2910390614\nArmstrong, 1975, Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices, Int J Cancer, 15, 617, 10.1002\u002Fijc.2910150411\nPhillips, 1980, Mortality among California Seventh-Day Adventists for selected cancer sites, J Natl Cancer Inst, 65, 1097\nKinlen, 1982, Meat and fat consumption and cancer mortality: a study of strict religious orders in Britain, Lancet, 1, 946, 10.1016\u002FS0140-6736(82)91943-2\nHowe, 1990, Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies, J Natl Cancer Inst, 82, 561, 10.1093\u002Fjnci\u002F82.7.561\nFrazier, 2004, Adolescent diet and risk of breast cancer, Cancer Causes Control, 15, 73, 10.1023\u002FB:CACO.0000016617.57120.df\nHunter, 1996, Cohort studies of fat intake and the risk of breast cancer--a pooled analysis, N Engl J Med, 334, 356, 10.1056\u002FNEJM199602083340603\nHolmes, 1999, Association of dietary intake of fat and fatty acids with risk of breast cancer, JAMA, 281, 914, 10.1001\u002Fjama.281.10.914\nBoyd, 2003, Dietary fat and breast cancer risk revisited: a meta-analysis of the published literature, Br J Cancer, 89, 1672, 10.1038\u002Fsj.bjc.6601314\nSieri, 2008, Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition, Am J Clin Nutr, 88, 1304, 10.3945\u002Fajcn.2008.26090\nChajès, 2008, Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study, Am J Epidemiol, 167, 1312, 10.1093\u002Faje\u002Fkwn069\n1998, Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group, Control Clin Trials, 19, 61, 10.1016\u002FS0197-2456(97)00078-0\nPrentice, 2006, Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial, JAMA, 295, 629, 10.1001\u002Fjama.295.6.629\nThomson, 2014, Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial, Cancer Epidemiol Biomark Prev, 23, 2924, 10.1158\u002F1055-9965.EPI-14-0922\nPierce, 2007, Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial, JAMA, 298, 289, 10.1001\u002Fjama.298.3.289\nChlebowski, 2006, Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study, J Natl Cancer Inst, 98, 1767, 10.1093\u002Fjnci\u002Fdjj494\nMartin, 2011, A randomized trial of dietary intervention for breast cancer prevention, Cancer Res, 71, 123, 10.1158\u002F0008-5472.CAN-10-1436\nMissmer, 2002, Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies, Int J Epidemiol, 31, 78, 10.1093\u002Fije\u002F31.1.78\nPala, 2009, Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, Am J Clin Nutr, 90, 602, 10.3945\u002Fajcn.2008.27173\nZheng, 1998, Well-done meat intake and the risk of breast cancer, J Natl Cancer Inst, 90, 1724, 10.1093\u002Fjnci\u002F90.22.1724\nGodos, 2017, Vegetarianism and breast, colorectal and prostate cancer risk: an overview and meta-analysis of cohort studies, J Hum Nutr Diet, 30, 349, 10.1111\u002Fjhn.12426\nSi, 2014, Egg consumption and breast cancer risk: a meta-analysis, Breast Cancer, 21, 251, 10.1007\u002Fs12282-014-0519-1\nMarcondes, 2019, Animal foods and postmenopausal breast cancer risk: a prospective cohort study, Br J Nutr, 1\nDeVries, 2006, Dioxins in organic eggs: a review, NJAS, 54, 2007\nEngeset, 2006, Fish consumption and breast cancer risk. The European Prospective Investigation into Cancer and Nutrition (EPIC), Int J Cancer, 119, 175, 10.1002\u002Fijc.21819\nDong, 2011, Dairy consumption and risk of breast cancer: a meta-analysis of prospective cohort studies, Breast Cancer Res Treat, 127, 23, 10.1007\u002Fs10549-011-1467-5\nChen, 2019, Milk and yogurt intake and breast cancer risk: a meta-analysis, Medicine, 98, e14900, 10.1097\u002FMD.0000000000014900\nChen, 2016, Dietary fibre intake and risk of breast cancer: a systematic review and meta-analysis of epidemiological studies, Oncotarget, 7, 80980, 10.18632\u002Foncotarget.13140\nFarvid, 2016, Dietary fiber intake in young adults and breast cancer risk, Pediatrics, 137, e20151226, 10.1542\u002Fpeds.2015-1226\nStarup-Linde, 2013, CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis, Curr Drug Saf, 8, 296, 10.2174\u002F15748863113086660071\nLarsson, 2007, Diabetes mellitus and risk of breast cancer: a meta-analysis, Int J Cancer, 121, 856, 10.1002\u002Fijc.22717\nLiao, 2011, Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature, Asian Pac J Cancer Prev, 12, 1061\nXue, 2007, Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence, Am J Clin Nutr, 86, s823, 10.1093\u002Fajcn\u002F86.3.823S\nWitte, 1997, Diet and premenopausal bilateral breast cancer: a case-control study, Breast Cancer Res Treat, 42, 243, 10.1023\u002FA:1005710211184\nAugustin, 2001, Dietary glycemic index and glycemic load, and breast cancer risk: a case-control study, Ann Oncol, 12, 1533, 10.1023\u002FA:1013176129380\nBradshaw, 2009, Consumption of sweet foods and breast cancer risk: a case-control study of women on Long Island, New York, Cancer Causes Control, 20, 1509, 10.1007\u002Fs10552-009-9343-x\nSchernhammer, 2005, Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk, Cancer Epidemiol Biomark Prev, 14, 699, 10.1158\u002F1055-9965.EPI-04-0561\nDoyle, 2012, Visceral obesity, metabolic syndrome, insulin resistance and cancer, Proc Nutr Soc, 71, 181, 10.1017\u002FS002966511100320X\nDong, 2011, Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies, Breast Cancer Res Treat, 126, 287, 10.1007\u002Fs10549-011-1343-3\nChazelas, 2019, Sugary drink consumption and risk of cancer: results from NutriNet-Santé prospective cohort, Br Med J, 366, l2408, 10.1136\u002Fbmj.l2408\nNagel, 2010, Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC), Breast Cancer Res Treat, 119, 753, 10.1007\u002Fs10549-009-0444-8\nEngel, 2011, Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort, Cancer Epidemiol Biomark Prev, 20, 187, 10.1158\u002F1055-9965.EPI-10-1039\nKühn, 2013, Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study, Int J Cancer, 133, 1689, 10.1002\u002Fijc.28172\nSperati, 2013, Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials, PLoS One, 8, e69269, 10.1371\u002Fjournal.pone.0069269\nLarsson, 2007, Folate and risk of breast cancer: a meta-analysis, J Natl Cancer Inst, 99, 64, 10.1093\u002Fjnci\u002Fdjk006\nGandini, 2000, Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients, Eur J Cancer, 36, 636, 10.1016\u002FS0959-8049(00)00022-8\nvan Gils, 2005, Consumption of vegetables and fruits and risk of breast cancer, JAMA, 293, 183, 10.1001\u002Fjama.293.2.183\nJung, 2013, Fruit and vegetable intake and risk of breast cancer by hormone receptor status, J Natl Cancer Inst, 105, 219, 10.1093\u002Fjnci\u002Fdjs635\nEmaus, 2016, Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort, Am J Clin Nutr, 103, 168, 10.3945\u002Fajcn.114.101436\nAdlercreutz, 1997, Phyto-oestrogens and Western diseases, Ann Med, 29, 95, 10.3109\u002F07853899709113696\nTaylor, 2009, The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies, Nutr Rev, 67, 398, 10.1111\u002Fj.1753-4887.2009.00213.x\nMessina, 2006, Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings, J Natl Cancer Inst, 98, 1275, 10.1093\u002Fjnci\u002Fdjj356\nTrock, 2006, Meta-analysis of soy intake and breast cancer risk, J Natl Cancer Inst, 98, 459, 10.1093\u002Fjnci\u002Fdjj102\nDong, 2011, Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies, Breast Cancer Res Treat, 125, 315, 10.1007\u002Fs10549-010-1270-8\nChen, 2014, Association between soy isoflavone intake and breast cancer risk for pre- and post-menopausal women: a meta-analysis of epidemiological studies, PLoS One, 9, e89288, 10.1371\u002Fjournal.pone.0089288\nFritz, 2013, Soy, red clover, and isoflavones and breast cancer: a systematic review, PLoS One, 8, e81968, 10.1371\u002Fjournal.pone.0081968\nTouillaud, 2019, Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study, Am J Clin Nutr, 109, 597, 10.1093\u002Fajcn\u002Fnqy313\nHamajima, 2002, Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease, Br J Cancer, 87, 1234, 10.1038\u002Fsj.bjc.6600596\nKey, 2006, Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues, Cancer Causes Control, 17, 759, 10.1007\u002Fs10552-006-0011-0\nTjønneland, 2007, Alcohol intake and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC), Cancer Causes Control, 18, 361, 10.1007\u002Fs10552-006-0112-9\nBessaoud, 2008, Patterns of alcohol (especially wine) consumption and breast cancer risk: a case-control study among a population in Southern France, Ann Epidemiol, 18, 467, 10.1016\u002Fj.annepidem.2008.02.001\n2007\nCottet, 2009, Postmenopausal breast cancer risk and dietary patterns in the E3N-EPIC prospective cohort study, Am J Epidemiol, 170, 1257, 10.1093\u002Faje\u002Fkwp257\nSchwingshackl, 2014, Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies, Int J Cancer, 135, 1884, 10.1002\u002Fijc.28824\nCouto, 2013, Mediterranean dietary pattern and risk of breast cancer, PLoS One, 8, e55374, 10.1371\u002Fjournal.pone.0055374\nSchwingshackl, 2017, Adherence to Mediterranean Diet and risk of cancer: an updated systematic review and meta-analysis, Nutrients, 9, 10.3390\u002Fnu9101063\nBuckland, 2013, Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study, Int J Cancer, 132, 2918, 10.1002\u002Fijc.27958\nHaridass, 2018, Diet quality scores inversely associated with postmenopausal breast cancer risk are not associated with premenopausal breast cancer rRisk in the California Teachers Study, J Nutr, 148, 1830, 10.1093\u002Fjn\u002Fnxy187\nXiao, 2019, Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies, Breast Cancer Res, 21, 16, 10.1186\u002Fs13058-019-1096-1\nFolsom, 1993, No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women's Health Study, Am J Epidemiol, 138, 380, 10.1093\u002Foxfordjournals.aje.a116870\nVatten, 1990, Coffee consumption and the risk of breast cancer. A prospective study of 14,593 Norwegian women, Br J Cancer, 62, 267, 10.1038\u002Fbjc.1990.274\nMichels, 2002, Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish women, Ann Epidemiol, 12, 21, 10.1016\u002FS1047-2797(01)00238-1\nNkondjock, 2006, Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers, Int J Cancer, 118, 103, 10.1002\u002Fijc.21296\nBhoo-Pathy, 2015, Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study, Breast Cancer Res, 17, 15, 10.1186\u002Fs13058-015-0521-3\nSun, 2006, Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies, Carcinogenesis, 27, 1310, 10.1093\u002Fcarcin\u002Fbgi276\nNie, 2014, Meta-analysis of black tea consumption and breast cancer risk: update 2013, Nutr Cancer, 66, 1009, 10.1080\u002F01635581.2014.936947\nYu, 2019, Green tea consumption and risk of breast cancer: a systematic review and updated meta-analysis of case-control studies, Medicine, 98, e16147, 10.1097\u002FMD.0000000000016147\nLinos, 2010, Adolescent diet in relation to breast cancer risk among premenopausal women, Cancer Epidemiol Biomark Prev, 19, 689, 10.1158\u002F1055-9965.EPI-09-0802\nLondon, 1989, Prospective study of smoking and the risk of breast cancer, J Natl Cancer Inst, 81, 1625, 10.1093\u002Fjnci\u002F81.21.1625\nBraga, 1996, Cigarette smoking and the risk of breast cancer, Eur J Cancer Prev, 5, 159, 10.1097\u002F00008469-199606000-00003\nAmbrosone, 1996, Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk, JAMA, 276, 1494, 10.1001\u002Fjama.1996.03540180050032\nBand, 2002, Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer, Lancet, 360, 1044, 10.1016\u002FS0140-6736(02)11140-8\nLawlor, 2004, Smoking before the birth of a first child is not associated with increased risk of breast cancer: findings from the British Women's Heart and Health Cohort Study and a meta-analysis, Br J Cancer, 91, 512, 10.1038\u002Fsj.bjc.6601916\nGram, 2005, Breast cancer risk among women who start smoking as teenagers, Cancer Epidemiol Biomark Prev, 14, 61, 10.1158\u002F1055-9965.61.14.1\nXue, 2011, Cigarette smoking and the incidence of breast cancer, Arch Intern Med, 171, 125, 10.1001\u002Farchinternmed.2010.503\nDeRoo, 2011, Smoking before the first pregnancy and the risk of breast cancer: a meta-analysis, Am J Epidemiol, 174, 390, 10.1093\u002Faje\u002Fkwr090\nMacacu, 2015, Active and passive smoking and risk of breast cancer: a meta-analysis, Breast Cancer Res Treat, 154, 213, 10.1007\u002Fs10549-015-3628-4\nDossus, 2014, Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort, Int J Cancer, 134, 1871, 10.1002\u002Fijc.28508\nTokunaga, 1994, Incidence of female breast cancer among atomic bomb survivors, 1950-1985, Radiat Res, 138, 209, 10.2307\u002F3578591\nMiller, 1989, Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis, N Engl J Med, 321, 1285, 10.1056\u002FNEJM198911093211902\nHoffman, 1989, Breast cancer in women with scoliosis exposed to multiple diagnostic x rays, J Natl Cancer Inst, 81, 1307, 10.1093\u002Fjnci\u002F81.17.1307\nHildreth, 1989, The risk of breast cancer after irradiation of the thymus in infancy, N Engl J Med, 321, 1281, 10.1056\u002FNEJM198911093211901\nAisenberg, 1997, High risk of breast carcinoma after irradiation of young women with Hodgkin's disease, Cancer, 79, 1203, 10.1002\u002F(SICI)1097-0142(19970315)79:6\u003C1203::AID-CNCR20>3.0.CO;2-2\nStorm, 1986, Risk of contralateral breast cancer in Denmark 1943-80, Br J Cancer, 54, 483, 10.1038\u002Fbjc.1986.201\nLundell, 1996, Breast cancer after radiotherapy for skin hemangioma in infancy, Radiat Res, 145, 225, 10.2307\u002F3579178\nFeig, 1997, Radiation risk from screening mammography of women aged 40-49 years, J Natl Cancer Inst Monogr, 22, 119, 10.1093\u002Fjncimono\u002F1997.22.119\nRonckers, 2005, Radiation and breast cancer: a review of current evidence, Breast Cancer Res, 7, 21, 10.1186\u002Fbcr970\nBreast cancer and organochlorines: a marker for susceptibility? – PubMed – NCBI [Internet]. [cité 30 mai 2017]. https:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fpubmed\u002F?term=Surg+Oncol.+1998%3B7(1-2)%3A1-4.\nHotz-Wagenblatt, 1993, Gap junctional communication and neoplastic transformation, Crit Rev Oncog, 4, 541\nRusso, 2004, Genotoxicity of steroidal estrogens, Trends Endocrinol Metab, 15, 211, 10.1016\u002Fj.tem.2004.05.007\nMusgrave, 1998, Breast cancer and organochlorines: a marker for susceptibility?, Surg Oncol, 7, 1, 10.1016\u002FS0960-7404(98)00010-3\nArdies, 1998, Xenoestrogens significantly enhance risk for breast cancer during growth and adolescence, Med Hypotheses, 50, 457, 10.1016\u002FS0306-9877(98)90262-6\nColborn, 1996\nBachelet, 2019, Breast cancer and exposure to organochlorines in the CECILE Study: Associations with plasma levels measured at the time of diagnosis and estimated during adolescence, Int J Environ Res Public Health, 16, 10.3390\u002Fijerph16020271\nWolff, 1993, Blood levels of organochlorine residues and risk of breast cancer, J Natl Cancer Inst, 85, 648, 10.1093\u002Fjnci\u002F85.8.648\nKrieger, 1994, Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women, J Natl Cancer Inst, 86, 589, 10.1093\u002Fjnci\u002F86.8.589\nHenderson, 1995, Breast cancer among women exposed to polybrominated biphenyls, Epidemiology, 6, 544, 10.1097\u002F00001648-199509000-00014\nHunter, 1997, Plasma organochlorine levels and the risk of breast cancer, N Engl J Med, 337, 1253, 10.1056\u002FNEJM199710303371801\nvan’t Veer, 1997, DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study, Br Med J, 315, 81, 10.1136\u002Fbmj.315.7100.81\nCohn, 2007, DDT and breast cancer in young women: new data on the significance of age at exposure, Environ Health Perspect, 115, 1406, 10.1289\u002Fehp.10260\nBrody, 2007, Environmental pollutants and breast cancer: epidemiologic studies, Cancer, 109, 2667, 10.1002\u002Fcncr.22655\nDanjou, 2015, Estimated dietary dioxin exposure and breast cancer risk among women from the French E3N prospective cohort, Breast Cancer Res, 17, 39, 10.1186\u002Fs13058-015-0536-9\nDanjou, 2019, Long-term airborne dioxin exposure and breast cancer risk in a case-control study nested within the French E3N prospective cohort, Environ Int, 124, 236, 10.1016\u002Fj.envint.2019.01.001\nAhern, 2019, Phthalate exposure and breast cancer incidence: a Danish nationwide cohort study, J Clin Oncol, 37, 1800, 10.1200\u002FJCO.18.02202\nTakkouche, 2005, Personal use of hair dyes and risk of cancer: a meta-analysis, JAMA, 293, 2516, 10.1001\u002Fjama.293.20.2516\nGera, 2018, Does the use of hair dyes increase the risk of developing breast cancer? A meta-analysis and review of the literature, Anticancer Res, 38, 707, 10.21873\u002Fanticanres.13028\nDarbre, 2004, Concentrations of parabens in human breast tumours, J Appl Toxicol, 24, 5, 10.1002\u002Fjat.958\nDarbre, 2005, Aluminium, antiperspirants and breast cancer, J Inorg Biochem, 99, 1912, 10.1016\u002Fj.jinorgbio.2005.06.001\nMcGrath, 2003, An earlier age of breast cancer diagnosis related to more frequent use of antiperspirants\u002Fdeodorants and underarm shaving, Eur J Cancer Prev, 12, 479, 10.1097\u002F00008469-200312000-00006\nMirick, 2002, Antiperspirant use and the risk of breast cancer, J Natl Cancer Inst, 94, 1578, 10.1093\u002Fjnci\u002F94.20.1578\nStevens, 1993, Breast cancer and electric power, Biomed Pharmacother, 47, 435, 10.1016\u002F0753-3322(93)90339-M\nTynes, 1993, Electromagnetic fields and male breast cancer, Biomed Pharmacother, 47, 425, 10.1016\u002F0753-3322(93)90337-K\nMcElroy, 2007, Occupational exposure to electromagnetic field and breast cancer risk in a large, population-based, case-control study in the United States, J Occup Environ Med, 49, 266, 10.1097\u002FJOM.0b013e318032259b\nLiu, 2016, The incidence of breast cancer among female flight attendants: an updated meta-analysis, J Travel Med, 23, 10.1093\u002Fjtm\u002Ftaw055\nCordina-Duverger, 2018, Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history, Eur J Epidemiol, 33, 369, 10.1007\u002Fs10654-018-0368-x\nMegdal, 2005, Night work and breast cancer risk: a systematic review and meta-analysis, Eur J Cancer, 41, 2023, 10.1016\u002Fj.ejca.2005.05.010\nTravis, 2016, Night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies, J Natl Cancer Inst, 108, 10.1093\u002Fjnci\u002Fdjw169\nCordina-Duverger, 2016, Night work and breast cancer risk defined by human epidermal growth factor receptor-2 (HER2) and hormone receptor status: a population-based case-control study in France, Chronobiol Int, 33, 783, 10.3109\u002F07420528.2016.1167709\nWang, 2013, A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer, Ann Oncol, 24, 2724, 10.1093\u002Fannonc\u002Fmdt283\nColditz, 1993, Epidemiology of breast cancer. Findings from the nurses’ health study, Cancer, 71, 1480, 10.1002\u002Fcncr.2820710413\nHartmann, 2005, Benign breast disease and the risk of breast cancer, N Engl J Med, 353, 229, 10.1056\u002FNEJMoa044383\n2001, Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease, Lancet, 358, 1389, 10.1016\u002FS0140-6736(01)06524-2\nOttman, 1983, Practical guide for estimating risk for familial breast cancer, Lancet, 2, 556, 10.1016\u002FS0140-6736(83)90580-9\nLynch, 1988, Breast cancer family history as a risk factor for early onset breast cancer, Breast Cancer Res Treat, 11, 263, 10.1007\u002FBF01807285\nAntoniou, 2003, Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies, Am J Hum Genet, 72, 1117, 10.1086\u002F375033\nKuchenbaecker, 2017, Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers, JAMA, 317, 2402, 10.1001\u002Fjama.2017.7112\nCybulski, 2015, Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis, Lancet Oncol, 16, 638, 10.1016\u002FS1470-2045(15)70142-7\nAntoniou, 2014, Breast-cancer risk in families with mutations in PALB2, N Engl J Med, 371, 497, 10.1056\u002FNEJMoa1400382\nBoyd, 2007, Mammographic density and the risk and detection of breast cancer, N Engl J Med, 356, 227, 10.1056\u002FNEJMoa062790\nBoyd, 1995, Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study, J Natl Cancer Inst, 87, 670, 10.1093\u002Fjnci\u002F87.9.670\nBreast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis – PubMed – NCBI [Internet]. https:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fpubmed\u002F?term=Mc+Cormak+Cancer+Epidemiol+Biomarkers+Prev.+2006%3B15(6)%3A1159%E2%80%931169.+doi%3A+10.1158%2F1055-9965.EPI-06-0034.\nBertrand, 2013, Mammographic density and risk of breast cancer by age and tumor characteristics, Breast Cancer Res, 15, R104, 10.1186\u002Fbcr3570\nColin, 2014, Mammographic density is not a worthwhile examination to distinguish high cancer risk women in screening, Eur Radiol, 24, 2412, 10.1007\u002Fs00330-014-3278-7\nRenzi, 2017, Memories of paternal relations are associated with coping and defense mechanisms in breast cancer patients: an observational study, BMC Psychol, 5, 37, 10.1186\u002Fs40359-017-0206-z\nBrown, 2016, Depression, antidepressant use, and postmenopausal breast cancer risk, Cancer Epidemiol Biomark Prev, 25, 158, 10.1158\u002F1055-9965.EPI-15-1063\nReeves, 2018, Depression, antidepressant use, and breast cancer risk in pre- and postmenopausal women: a prospective cohort study, Cancer Epidemiol Biomark Prev, 27, 306, 10.1158\u002F1055-9965.EPI-17-0707\nJasmin, 1990, Evidence for a link between certain psychological factors and the risk of breast cancer in a case-control study. Psycho-Oncologic Group (P.O.G.), Ann Oncol, 1, 22, 10.1093\u002Foxfordjournals.annonc.a057666",{"ES":783},"Epidemiología del cáncer de mama",{"VOID":785},"10.1016\u002Fs1283-081x(20)43722-1","2024-12-12T20:50:29.888+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437221",[789,804,816,840,859,871,883,906],{"id":790,"sortIndex":111,"researcher":26,"roles":791,"affiliations":792,"properties":801},"508ebd2e-6f42-4ce1-93d4-aebea3ed00dd",[696],[793],{"id":26,"sortIndex":36,"affiliation":794,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":797,"slug":26,"properties":798,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"ea4cd678-b5dd-418d-ad3c-d2589ee83fb2","2024-01-01T14:14:24.440+00:00",[],{"title":799},{"VI":800},"Centre des maladies du sein, Sénopôle Saint-Louis, Territoire Nord, AP–HP, 1, avenue Claude-Vellefaux, 75010 Paris, France",{"title":802},{"VI":803},"E. Bourstyn",{"id":805,"sortIndex":158,"researcher":26,"roles":806,"affiliations":807,"properties":813},"f62b67e1-2ac0-4ee8-ac94-324a2e28310e",[696],[808],{"id":26,"sortIndex":36,"affiliation":809,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":810,"slug":26,"properties":811,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":812},{"VI":800},{"title":814},{"VI":815},"L. Teixeira",{"id":817,"sortIndex":59,"researcher":26,"roles":818,"affiliations":819,"properties":837},"4f4e931d-ce4f-46e6-89c0-2e756d38082a",[696],[820,825],{"id":26,"sortIndex":36,"affiliation":821,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":822,"slug":26,"properties":823,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":824},{"VI":800},{"id":826,"sortIndex":115,"affiliation":827,"properties":836},"351be4b9-5219-4424-971b-fe4494de7434",{"id":828,"createTime":829,"updateTime":830,"relativeEntities":831,"slug":832,"properties":833,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a56ee104-ad59-47a7-962b-21444e96681e","2024-02-07T17:34:24.931+00:00","2024-10-15T11:02:11.754+00:00",[],"Universit%C3%A9-Paris-Diderot-Paris-France",{"title":834},{"VI":835},"Université Paris-Diderot, Paris, France",{},{"title":838},{"VI":839},"V. de Castelbajac",{"id":841,"sortIndex":36,"researcher":26,"roles":842,"affiliations":843,"properties":856},"09d9564e-9554-4fac-914f-1deb49767ea3",[696],[844,849],{"id":26,"sortIndex":36,"affiliation":845,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":846,"slug":26,"properties":847,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":848},{"VI":800},{"id":850,"sortIndex":115,"affiliation":851,"properties":855},"2f632f0e-c8d9-422b-858d-0528ff2f2a6e",{"id":828,"createTime":829,"updateTime":830,"relativeEntities":852,"slug":832,"properties":853,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":854},{"VI":835},{},{"title":857},{"VI":858},"M. Espié",{"id":860,"sortIndex":135,"researcher":26,"roles":861,"affiliations":862,"properties":868},"053ff426-b37b-4a7a-a630-75c3c11e6fdd",[696],[863],{"id":26,"sortIndex":36,"affiliation":864,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":865,"slug":26,"properties":866,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":867},{"VI":800},{"title":869},{"VI":870},"S. Giacchetti",{"id":872,"sortIndex":162,"researcher":26,"roles":873,"affiliations":874,"properties":880},"9cf5ac2a-1bb6-400c-952d-7fbd4694d631",[696],[875],{"id":26,"sortIndex":36,"affiliation":876,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":877,"slug":26,"properties":878,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":879},{"VI":800},{"title":881},{"VI":882},"C. Cuvier",{"id":884,"sortIndex":115,"researcher":26,"roles":885,"affiliations":886,"properties":903},"cc059c23-385e-47d7-a0cb-8684c40ee6ae",[696],[887,892],{"id":26,"sortIndex":36,"affiliation":888,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":889,"slug":26,"properties":890,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":891},{"VI":800},{"id":893,"sortIndex":115,"affiliation":894,"properties":902},"d607364e-b279-4055-bdd3-085a8353b5d1",{"id":895,"createTime":896,"updateTime":897,"relativeEntities":898,"slug":832,"properties":899,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"764036c0-e285-4a51-9010-540377d35422","2024-02-12T14:34:28.149+00:00","2025-02-05T17:39:35.287+00:00",[],{"title":900},{"VI":901},"Université Paris Diderot, Paris, France",{},{"title":904},{"VI":905},"O. Nguyen",{"id":907,"sortIndex":114,"researcher":26,"roles":908,"affiliations":909,"properties":915},"e42cd2a9-3169-4df0-96b2-c2447caaacdd",[696],[910],{"id":26,"sortIndex":36,"affiliation":911,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":912,"slug":26,"properties":913,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":914},{"VI":800},{"title":916},{"VI":917},"G. Douchet",{"url":787,"publisher":919,"properties":927},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":920,"slug":662,"properties":921,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":924,"manageAffiliations":925,"indexDatabases":926,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":922,"title":923},{"VOID":665},{"EN":667},[],[],[],{"volume":928,"pages":929},{"VOID":759},{"VOID":930},"1-21",{"id":932,"createTime":933,"updateTime":933,"relativeEntities":934,"slug":26,"properties":935,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":942,"fullTextUrl":26,"authors":943,"publicationType":747,"publisherRelationship":959,"citationCount":26,"citationInfo":26,"publishDate":973,"publishYear":974,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"ccafdccf-a197-40e7-bb57-51212ce62eac","2024-01-18T02:04:33.873+00:00",[],{"references":936,"title":938,"doi":940},{"VOID":937},"Kallen, 2010, Trends in delivery and neonatal outcome after in vitro fertilization in Sweden: data for 25 years, Hum. Reprod., 25, 1026, 10.1093\u002Fhumrep\u002Fdeq003\nDe la Rochebrochard, 2008, 200 000 enfants conçus par fécondation in vitro en France depuis 30 ans, Popul. Soc. (Paris), 451, 1\nNyboe Andersen, 2009, The European I VF Monitoring Programme (EIM) for the European Society of Human reproduction and Embryology (ESHRE). Assisted reproductive technology and intrauterine inseminations in Europe 2005: results generated from European registers by ESHRE, Hum. Reprod., 24, 1267, 10.1093\u002Fhumrep\u002Fdep035\nBelaisch-Allart, 2008, Désir tardif d'enfant : les risques materno-fœtaux, 73\nGhazi, 1991, Delivery outcome after infertility -a registry study, Fertil. Steril., 55, 726, 10.1016\u002FS0015-0282(16)54238-1\nBasso, 2003, Infertility and preterm delivery, birthweight and Caesarian section: a study within the Danish national birth Cohort, Hum. Reprod., 11, 2478, 10.1093\u002Fhumrep\u002Fdeg444\nJaques, 2010, Adverse obstetric and perinatal outcomes in subfertile women conceiving without reproductive technologies, Fertil. Steril., 94, 2674, 10.1016\u002Fj.fertnstert.2010.02.043\nZhu, 2006, Infertility, infertility treatment and congenital malformations: Danish national birth cohort, BMJ, 333, 665, 10.1136\u002Fbmj.38919.495718.AE\nAddor, 1998, Impact of fertility treatments on the health of newborn, Fertil. Steril., 69, 210, 10.1016\u002FS0015-0282(97)00468-8\nKallen, 2002, Neonatal outcome in pregnancies from ovarian stimulation, Obstet. Gynecol., 100, 414\nNuojua-Huttunen, 1999, Obstetric and perinatal outcome of pregnancies after intrauterine insemination, Hum. Reprod., 14, 2110, 10.1093\u002Fhumrep\u002F14.8.2110\nOmbelet, 2006, Perinatal outcome of 12 021 singleton and 3 108 twin births after non IVF assisted reproduction: a cohort study, Hum. Reprod., 21, 1025, 10.1093\u002Fhumrep\u002Fdei419\nKlemetti, 2010, Health of children born after ovulation induction, Fertil. Steril., 93, 1157, 10.1016\u002Fj.fertnstert.2008.12.025\nDe Sutter, 2005, Comparison of outcome of pregnancy after intra-uterine insemination and IVF, Hum. Reprod., 20, 1642, 10.1093\u002Fhumrep\u002Fdeh807\nThepot, 1996, Incidence of birth defect after artificial insemination with frozen donor spermatozoa: a collaborative study of the French CECOS Federation on 11 535 pregnancies, Hum. Reprod., 11, 2319, 10.1093\u002Foxfordjournals.humrep.a019097\nSmith, 1997, Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility, Am. J. Obstet. Gynecol., 177, 455, 10.1016\u002FS0002-9378(97)70215-1\nFIVNAT. Dossier FIVNAT Edition 2006. Organon en fertilité. Bilan général 2000-2004. p. 7-44.\nInt-Veld, 1995, Increased incidence of cytogenetic abnormalities in chorionic villus samples from pregnancies established by in vitro fertilization and embryo transfer, Prenat. Diagn., 5, 975, 10.1002\u002Fpd.1970151014\nLambers, 2007, Factors determining early pregnancy loss in singleton and multiple implantations, Hum. Reprod., 22, 275, 10.1093\u002Fhumrep\u002Fdel367\nJambon, 1998, Le devenir des grossesses après FIV, Contracept. Fertil. Sex., 26, 323\nClayton, 2007, A comparison of heterotopic and intrauterine only pregnancy outcomes after assisted reproductive technologies in the United States from 1999 to 2002, Fertil. Steril., 87, 303, 10.1016\u002Fj.fertnstert.2006.06.037\nDhont, 1999, Perinatal outcome of pregnancies after assisted reproduction: a case-control study, Am. J. Obstet. Gynecol., 181, 688, 10.1016\u002FS0002-9378(99)70514-4\nJackson, 2004, Perinatal outcome in singletons following in vitro fertilization: a meta analysis, Obstet. Gynecol., 103, 551, 10.1097\u002F01.AOG.0000114989.84822.51\nHalliday, 2007, Outcomes of IVF conceptions: are they different?, Best Pract Res Clin Obstet Gynecol, 21, 67, 10.1016\u002Fj.bpobgyn.2006.08.004\nWisborg, 2010, In vitro fertilization and preterm delivery, low birth weight and admission to the neonatal intensive care unit: a prospective follow-up study, Fertil. Steril., 94, 2102, 10.1016\u002Fj.fertnstert.2010.01.014\nMc Donald, 2005, Perinatal outcomes of singleton pregnancies achieved by in vitro fertilization: a systematic review and meta analysis, J Obstet Gynecol Can, 27, 449, 10.1016\u002FS1701-2163(16)30527-8\nHelmerhorst, 2004, Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies, BMJ, 328, 261, 10.1136\u002Fbmj.37957.560278.EE\nHernandez-Diaz, 2007, Gestationnal hypertension in pregnancies supported by infertility treatments: role of infertility, treatments and multiple gestations, Fertil. Steril., 88, 438, 10.1016\u002Fj.fertnstert.2006.11.131\nLambert, 2003, Safety issues in assisted reproductive technology: aetiology of health problems in singleton ART babies, Hum. Reprod., 18, 1987, 10.1093\u002Fhumrep\u002Fdeg361\nDe Geyter, 2006, Comparative birth weights of singleton born after assisted reproduction and natural conception in previously infertile women, Hum. Reprod., 21, 705, 10.1093\u002Fhumrep\u002Fdei378\nDickey, 2002, Spontaneous reduction of multiple pregnancy: incidence and effect on outcome, Am. J. Obstet. Gynecol., 186, 77, 10.1067\u002Fmob.2002.118915\nPinborg, 2007, Vanishing twins: a predictor for small for gestational age in IVF singleton, Hum. Reprod., 22, 2707, 10.1093\u002Fhumrep\u002Fdem225\nDe Neubourg, 2006, The obstetrical and neonatal outcome of babies born after single-embryo transfer in IVF\u002FICSI compares favourably to spontaneously conceived babies, Hum. Reprod., 21, 1041, 10.1093\u002Fhumrep\u002Fdei424\nFujii, 2010, Perinatal risk in singleton pregnancies after in vitro fertilization, Fertil. Steril., 94, 2113, 10.1016\u002Fj.fertnstert.2009.12.031\nGriesinger, 2008, Ovarian Stimulation for IVF has no quantitative association with birthweigth: a registry study, Hum. Reprod., 23, 2549, 10.1093\u002Fhumrep\u002Fden286\nWisborg, 2010, IVF and stillbirth: a prospective follow-up study, Hum. Reprod., 25, 1312, 10.1093\u002Fhumrep\u002Fdeq023\nOlivennes, 2002, Perinatal outcome and developmental studies on children born after IVF, Hum. Reprod. Update, 7, 117, 10.1093\u002Fhumupd\u002F8.2.117\nEricson, 2001, Congenital malformations in infants born after IVF: a population-based study, Hum. Reprod., 16, 504, 10.1093\u002Fhumrep\u002F16.3.504\nKlemetti, 2005, Children born after assisted fertilization have an increased rate of major congenital malformations, Fertil. Steril., 84, 1300, 10.1016\u002Fj.fertnstert.2005.03.085\nSutcliffe, 2007, Outcome of assisted reproduction, Lancet, 370, 351, 10.1016\u002FS0140-6736(07)60456-5\nHansen, 2002, The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization, N. Engl. J. Med., 346, 725, 10.1056\u002FNEJMoa010035\nHansen, 2005, Assisted reproductive technologies and the risk of birth defects - A systematic review, Hum. Reprod., 20, 328, 10.1093\u002Fhumrep\u002Fdeh593\nHallouf, 2009, ICSI chirurgicales : quels enfants ?, Gynecol Obstet Fertil, 37, 873, 10.1016\u002Fj.gyobfe.2009.09.007\nDe Groot, 1993, Genomic imprinting and β-chorionic gonadotropin, Prenat. Diagn., 13, 1159, 10.1002\u002Fpd.1970131214\nMaher, 2003, Epigenetic risks related to assisted reproductive technologies: epigenetics, imprinting, ART and icebergs?, Hum. Reprod., 18, 2508, 10.1093\u002Fhumrep\u002Fdeg486\nGicquel, 2003, In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene, Am. J. Hum. Genet., 72, 1338, 10.1086\u002F374824\nCox, 2002, Intracytoplasmic sperm injection may increase the risk of imprinting defects, Am. J. Hum. Genet., 71, 162, 10.1086\u002F341096\nSvensson, 2005, Increased risk of Silver-Russell syndrome after in vitro fertilization?, Acta Paediatr., 94, 1163, 10.1111\u002Fj.1651-2227.2005.tb02066.x\nKagami, 2007, Silver-Russell syndrome in a girl born after in vitro fertilization: partial hypermethylation at the differentially methylated region of PEG1\u002FMEST, J. Assist. Reprod. Genet., 24, 131, 10.1007\u002Fs10815-006-9096-3\nDouzgou, 2008, Silver-Russell syndrome following in vitro fertilization, Pediatr. Dev. Pathol., 11, 329, 10.2350\u002F08-04-0458.1\nMoll, 2003, In vitro fertilization and retinoblastoma, Lancet, 361, 1392, 10.1016\u002FS0140-6736(03)13065-6\nLee, 2005, Retinoblastoma in a child conceived by in vitro fertilization, Br. J. Ophthalmol., 89, 393\nLidegaard, 2005, Imprinting diseases and IVF: Danish National IVF cohort study, Hum. Reprod., 20, 950, 10.1093\u002Fhumrep\u002Fdeh714\nBowdin, 2007, A survey of assisted reproductive technology births and imprinting disorders, Hum. Reprod., 22, 3237, 10.1093\u002Fhumrep\u002Fdem268\nDoornbos, 2007, Infertility, assisted reproduction technologies and imprinting disturbances: a Dutch study, Hum. Reprod., 22, 2476, 10.1093\u002Fhumrep\u002Fdem172\nKobayashi, 2007, Aberrant DNA methylation of imprinted loci in sperm from oligospermic patients, Hum. Mol. Genet., 16, 2542, 10.1093\u002Fhmg\u002Fddm187\nKobayashi, 2009, Identification of the mouse paternally expressed imprinted gene Zdbf2 on chromosome 1 and its imprinted human homolog ZDBF2 on chromosome 2, Genomics, 93, 461, 10.1016\u002Fj.ygeno.2008.12.012\nBasatemur, 2010, Growth of children conceived by IVF and ICSI up to 12 years of age reproductive, BioMedicine Online, 20, 144, 10.1016\u002Fj.rbmo.2009.10.006\nViot, 2010, Is there an increased risk of congenital malformations after ART? Results of a prospective French long-term survey of a cohort of 15 0162 children, Hum. Reprod., 25, i54\n2005, FIVNAT préparé par Belaisch-Allart J, de Mouzon J, Pouly JL, Ayel JP. Grossesses gémellaires après AMP, Gynecol. Obstet. Fertil., 33, 602\nMoise, 1998, The outcome of twin pregnancies after IVF, Hum. Reprod., 13, 1702, 10.1093\u002Fhumrep\u002F13.6.1702\nKoudstaal, 2000, Obstetric outcome of twin pregnancies after in-vitro fertilization: a matched control study in four Dutch university hospitals, Hum. Reprod., 15, 935, 10.1093\u002Fhumrep\u002F15.4.935\nBernasko, 1997, Twin pregnancies conceived by assisted reproductive techniques: maternal and neonatal outcomes, Obstet. Gynecol., 89, 368, 10.1016\u002FS0029-7844(96)00527-3\nPetersen, 1995, Perinatal outcome after in vitro fertilisation, Acta Obstet. Gynecol. Scand., 74, 129, 10.3109\u002F00016349509008921\nOlivennes, 1996, Perinatal outcome of twin pregnancies obtained after in vitro fertilization: comparison with twin pregnancies obtained spontaneously or after ovarian stimulation, Fertil. Steril., 66, 105, 10.1016\u002FS0015-0282(16)58395-2\nLuke, 2004, Risk factors for adverse outcomes in spontaneous versus assisted conception twin pregnancies, Fertil. Steril., 81, 315, 10.1016\u002Fj.fertnstert.2003.07.012\nPinborg, 2004, Neonatal outcome in a Danish national cohort of 3438 IVF\u002FICSI and 10 362 non-IVF\u002FICSI twins born between 1995 and 2000, Hum. Reprod., 19, 435, 10.1093\u002Fhumrep\u002Fdeh063\nPons, 1991, Prise en charge des grossesses gémellaires : 10 ans d'expérience d'un centre de référence, 95\nChild, 2004, The desire for multiples pregnancies in male and female infertility patients, Hum. Reprod., 19, 558, 10.1093\u002Fhumrep\u002Fdeh097\nPinborg, 2003, Attitudes of IVF\u002FICSI-twin mothers towards twins and single embryo transfer, Hum. Reprod., 18, 621, 10.1093\u002Fhumrep\u002Fdeg145\nTimor-Tritsch, 2004, Two hundred ninety consecutive cases of multifetal pregnancy reduction: comparison of the transabdominal versus the transvaginal approach, Am. J. Obstet. Gynecol., 191, 2085, 10.1016\u002Fj.ajog.2004.05.024\nPinborg, 2005, Vanishing twins: consequences of vanishing twins in IVF\u002FICSI pregnancies, Hum. Reprod., 20, 2821, 10.1093\u002Fhumrep\u002Fdei142\nOmbelet, 2005, Perinatal outcome of ICSI pregnancies compared with a matched group of natural conception pregnancies in Flanders (Belgium): a cohort study, Reprod. Biomed. Online, 11, 244, 10.1016\u002FS1472-6483(10)60965-0\nBonduelle, 2002, Neonatal data on a cohort of 2 889 infants born after ICSI (1991-1999) and of 2 995 infants born after IVF (1983-1999), Hum. Reprod., 17, 671, 10.1093\u002Fhumrep\u002F17.3.671\nLeunens, 2008, Follow-up of cognitive and motor development of 10 years old singleton children born after ISCI compared with spontaneously conceived children, Hum. Reprod., 23, 105, 10.1093\u002Fhumrep\u002Fdem257\nLudwig, 2003, For the german ICSI follow-up study group pregnancy course and health of children born after ICSI depending on parameters of male infertility, Hum. Reprod., 18, 351, 10.1093\u002Fhumrep\u002Fdeg048\nBonduelle, 2005, A multicentre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception, Hum. Reprod., 20, 413, 10.1093\u002Fhumrep\u002Fdeh592\n1997, Kurinczukj, Bower C. Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation, BMJ, 315, 1260, 10.1136\u002Fbmj.315.7118.1260\nBonduelle, 1996, Prospective follow-up study of 877 children born after intracytoplasmic sperm injection (ICSI), with ejaculated epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI, Hum. Reprod., 11, 131, 10.1093\u002Fhumrep\u002F11.suppl_4.131\nBuffat, 2006, ICSI outcomes in obstructive azoospermia: influence of the origin of surgically retrieved spermatozoa and the cause of obstruction, Hum. Reprod., 21, 1018, 10.1093\u002Fhumrep\u002Fdei418\nWoldringh, 2010, Karyotyping. Congenital anomalies and follow-up of children after intracytoplasmic sperm injection with non-ejaculated sperm: a systematic review, Hum. Reprod. Update, 16, 12, 10.1093\u002Fhumupd\u002Fdmp030\nDulioust, 1995, Long-term effects of embryo freezing in mice, Proc. Natl. Acad. Sci. USA, 92, 589, 10.1073\u002Fpnas.92.2.589\n1994, Comparaison des grossesses issues de transferts d'embryons congelés aux grossesses issues de transferts d'embryons frais en fécondation in vitro, Contracept. Fertil. Sex., 22, 287\nPelkonen, 2010, Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995-2006, Hum. Reprod., 25, 914, 10.1093\u002Fhumrep\u002Fdep477\nWennerholm, 2009, Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data, Hum. Reprod., 24, 2158, 10.1093\u002Fhumrep\u002Fdep125\nChen, 1986, Pregnancy after human oocyte cryopreservation, Lancet, 1, 884, 10.1016\u002FS0140-6736(86)90989-X\nNoyes, 2009, Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies, Reprod. Biomed. Online, 18, 769, 10.1016\u002FS1472-6483(10)60025-9\nDesai, 2010, Clinical pregnancy and live births after transfer of embryos vitrified on day 3, Reprod. Biomed. Online, 6, 808, 10.1016\u002Fj.rbmo.2010.02.010\nWikland, 2010, Obstetric outcomes after transfer of vitrified blastocysts, Hum. Reprod., 25, 1699, 10.1093\u002Fhumrep\u002Fdeq117\nLutjen, 1994, The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure, Nature, 307, 174, 10.1038\u002F307174a0\nSimchen, 2006, Pregnancy outcome after age 50, Obstet. Gynecol., 108, 1084, 10.1097\u002F01.AOG.0000240139.46018.bd\nSunol-Sala, 2007, Evolution of clinical pregnancies obtained from patients > 45 years old receiving oocyte donations, Hum. Reprod., 22, i102\nFenichel, 2010, Materno fœtal cardiovascular complications after oocyte donation in Turner syndrome: a very high risk pregnancy, Hum. Reprod., 25, i22, 10.1093\u002Fhumrep\u002Fde.25.s1.15\nVan der Hoorn, 2010, Clinical and immunologic aspects of egg donation pregnancies: a systematic review, Hum. Reprod. Update, 16, 704, 10.1093\u002Fhumupd\u002Fdmq017\nKeenan, 2008, Favorable pregnancy, delivery, and implantation rates experienced in embryo donation programs in the United States, Fertil. Steril., 90, 1077, 10.1016\u002Fj.fertnstert.2007.07.1327\nLibaers, 2010, Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis, Hum. Reprod., 25, 275, 10.1093\u002Fhumrep\u002Fdep298\nLudwig, 2006, Postnatal health and development of children born after assisted reproduction: a systematic review of controlled studies, Eur J Obstet Gyneco Reprod Biol, 127, 3, 10.1016\u002Fj.ejogrb.2006.02.009\nHansen, 2008, Admission to hospital of singleton children born following assisted reproductive technology (ART), Hum. Reprod., 23, 1297, 10.1093\u002Fhumrep\u002Fden093\nRaimondi, 2005, Meta-analysis of cancer incidence in children born after assisted reproductive technologies, Br. J. Cancer, 93, 1053, 10.1038\u002Fsj.bjc.6602838\nMiddelburg, 2008, Neuromotor, cognitive language and behavioural outcome in children born following IVF or ISCI a systematic review, Hum. Reprod. Update, 14, 219, 10.1093\u002Fhumupd\u002Fdmn005\nLeslie, 2003, Children conceived using ICSI do not have an increased risk of delayed mental development at 5 years of age, Hum. Reprod., 18, 2067, 10.1093\u002Fhumrep\u002Fdeg408\nMau Kai, 2007, Reduced serum testosterone levels in infant boys conceived by intracytoplasmic sperm injection, J. Clin. Endocrinol. Metab., 92, 2598, 10.1210\u002Fjc.2007-0095\nMurray, 2006, Egg donation parents and their children: follow-up at age 12 years, Fertil. Steril., 85, 610, 10.1016\u002Fj.fertnstert.2005.08.051\nGuibert, 2006, Le suivi des enfants nés par assistance médicale à la procréation, Réal Gynécol-Obstét, 108, 29\nAntoine, 2009, Grossesses et enfants issus de couples infertiles, J. Gynecol. Obstet. Biol. Reprod. (Paris), 38, F53, 10.1016\u002FS0368-2315(09)70232-7\nEpelboin, 2007, Les enfants de l'ICSI, J. Gynecol. Obstet. Biol. Reprod. (Paris), 36, 109, 10.1016\u002FS0368-2315(07)78742-2",{"ES":939},"Reproducción asistida",{"VOID":941},"10.1016\u002Fs1283-081x(11)71083-9","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X11710839",[944],{"id":945,"sortIndex":36,"researcher":26,"roles":946,"affiliations":947,"properties":956},"a0c42ed4-a312-4cc0-8fc8-882268438038",[696],[948],{"id":26,"sortIndex":36,"affiliation":949,"properties":26},{"id":950,"createTime":951,"updateTime":951,"relativeEntities":952,"slug":26,"properties":953,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"374f3954-dbe3-41d4-9b47-c3b436ef84e2","2024-01-18T02:04:33.884+00:00",[],{"title":954},{"VI":955},"Service de gynécologie-obstétrique et médecine de la reproduction, Centre hospitalier des Quatre villes, site de Sèvres, 141, Grande-Rue, BP 83, 92318 Sèvres cedex, France",{"title":957},{"VI":958},"J. Belaisch-Allart",{"url":942,"publisher":960,"properties":968},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":961,"slug":662,"properties":962,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":965,"manageAffiliations":966,"indexDatabases":967,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":963,"title":964},{"VOID":665},{"EN":667},[],[],[],{"volume":969,"pages":971},{"VOID":970},"47",{"VOID":972},"1-11","2011-01-01",2011,{"id":976,"createTime":977,"updateTime":978,"relativeEntities":979,"slug":980,"properties":981,"entityType":688,"verifyStatus":28,"verifyTime":978,"verifyNote":986,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":987,"fullTextUrl":26,"authors":988,"publicationType":747,"publisherRelationship":989,"citationCount":26,"citationInfo":26,"publishDate":1004,"publishYear":1005,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a6a9e75a-3096-455a-b3b9-a942dbc2777e","2024-01-29T09:44:18.178+00:00","2025-02-24T09:51:26.994+00:00",[],"Hernia-de-c%C3%BApula-diafragm%C3%A1tica",{"title":982,"doi":984},{"EN":983},"Hernia de cúpula diafragmática",{"VOID":985},"10.1016\u002FS1283-081X(07)70821-4","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X07708214",[],{"url":987,"publisher":990,"properties":998},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":991,"slug":662,"properties":992,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":995,"manageAffiliations":996,"indexDatabases":997,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":993,"title":994},{"VOID":665},{"EN":667},[],[],[],{"volume":999,"pages":1001,"issue":1002},{"VOID":1000},"43",{"VOID":761},{"VOID":1003},"4","2007-01-01",2007,{"id":1007,"createTime":1008,"updateTime":1009,"relativeEntities":1010,"slug":1011,"properties":1012,"entityType":688,"verifyStatus":25,"verifyTime":1009,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1019,"fullTextUrl":26,"authors":1020,"publicationType":747,"publisherRelationship":1111,"citationCount":26,"citationInfo":26,"publishDate":1125,"publishYear":1126,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e171e04f-e399-4a02-b3bf-f8a6ebc16f2c","2024-02-10T01:05:26.301+00:00","2025-02-24T12:32:42.402+00:00",[],"El-l%C3%A1ser-en-ginecolog%C3%ADa",{"references":1013,"title":1015,"doi":1017},{"VOID":1014},"Guillet, 1990, Lasers : applications médicales\nKamami, 1997\nApfelberg, 1987, Biophysics, advantages, and installation of laser systems, 1\nMordon, 1992, Bases physiques des applications thérapeutiques des lasers, Neurochirurgie, 38, 203\nBoulnois, 1986, Photophysical process in recent medical laser development, Lasers Med. Sci., 1, 47, 10.1007\u002FBF02030737\nDelcroix, 1994, Les infections vulvaires, 140\nBoulanger, 1990, Place du laser dans le traitement des infections à HPV de la femme, 265\nRiva, 1989, Extended carbon dioxyd laser vaporization in the treatment of subclinical papilloma virus infection of the lower genital tract, Obstet. Gynecol., 73, 25\nBaldauf JJ, Hamid D, Ritter J, Walter P. Néoplasies intra-épithéliales du col. Encycl Méd Chir (Elsevier SAS, Paris), Gynécologie 597-A-10, 2003 : 20p.\nBody G, Descamps P, Lansac J, Fetissof F, Fignon A, Jourdan ML, et al. Néoplasies intra-épithéliales du col. Encycl Méd Chir (Elsevier SAS, Paris), Gynécologie, 597-A-10, Cancérologie, 60-200-A-10, 1993.\nBaggish, 1989, A ten years experience treating cervical intraepithelial neoplasia with the CO2 laser, Am J Gynecol Obstet, 161, 60, 10.1016\u002F0002-9378(89)90233-0\n1984\nYamaguchi, 2005, Photodynamic therapy for cervical intraepithelial neoplasia, Oncology, 69, 110, 10.1159\u002F000087812\nHagen, 1998, CO2 laser conization for cervical intraepithelial neoplasia grade II-III: complications and efficacy, Acta Obstet. Gynecol. Scand., 77, 558, 10.1080\u002Fj.1600-0412.1998.770515.x\nHoulard, 2002, Risk factors for cervical stenosis after laser cone biopsy, Eur. J. Obstet. Gynecol. Reprod. Biol., 104, 144, 10.1016\u002FS0301-2115(02)00062-3\nBaldauf, 1997, Conséquences et traitement des sténoses cervicales survenues après une conisation au laser ou une résection à l'anse diathermique, J. Gynecol. Obstet. Biol. Reprod. (Paris), 26, 64\nBekassy, 1997, Long-term follow-up of cervical intraepithelial neoplasia treated with minimal conization by carbon dioxide laser, Lasers Surg. Med., 20, 461, 10.1002\u002F(SICI)1096-9101(1997)20:4\u003C461::AID-LSM13>3.0.CO;2-E\nJones, 2005, Vulvar Intraepithelial Neoplasia. Aspects of the natural history and outcome in 405 women, Obstet. Gynecol., 106, 1319, 10.1097\u002F01.AOG.0000187301.76283.7f\nSpuhler, 1995, Néoplasies intra-épithéliales vulvaires (VIN) diagnostic et traitement, Ref. Gynecol. Obstet., 3, 164\nWright, 1987, Laser surgery for intraepithelial neoplasia, Am. J. Obstet. Gynecol., 156, 374, 10.1016\u002F0002-9378(87)90287-0\nLouis-Sylvestre, 2001, Paget's disease of the vulva: results of different conservative treatments, Eur. J. Obstet. Gynecol. Reprod. Biol., 99, 253, 10.1016\u002FS0301-2115(01)00394-3\nHillemanns, 2006, Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO2 laser vaporization, photodynamic therapy, excision and vulvectomy, Gynecol. Oncol., 100, 271, 10.1016\u002Fj.ygyno.2005.08.012\nSillman, 1985, A review of lower genital intraepithelial neoplasia and the use of topical 54-fluorouracil, Obstet. Gynecol. Surv., 40, 190, 10.1097\u002F00006254-198504000-00002\nDiakomanolis, 1996, Conservative management of vaginal intraepithelial neoplasia (VAIN) by laser CO2, Eur J Oncol, 5, 389\nBruhat, 1979, Use of the CO2 laser in laparoscopy\nDonnez, 1990, Neodymium: YAG-laser hysteroscopy in large submucous fibroids, Fertil. Steril., 54, 999, 10.1016\u002FS0015-0282(16)53994-6\nDonnez, 1992, The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniques, Br. J. Obstet. Gynaecol., 99, 31, 10.1111\u002Fj.1471-0528.1992.tb13537.x\nLuciano, 1995, Laparoscopic adhesiolysis, Ref. Gynecol. Obstet., 3, 119\nNezhat, 1990, Adhesion reformation after reproductive surgery by videolaseroscopy, Fertil. Steril., 53, 1008, 10.1016\u002FS0015-0282(16)53576-6\nSutton, 1997, Follow-up report on a randomized controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal to moderate endometriosis, Fertil. Steril., 68, 1070, 10.1016\u002FS0015-0282(97)00403-2\nMarcoux, 1997, Laparoscopic surgery in infertile women with minimal or mild endometriosis, N Engl J Med, 337, 217, 10.1056\u002FNEJM199707243370401\nParazzini, 1999, Ablation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomized trial. Gruppo Italiano per lo Studio dell'Endometriosi, Hum. Reprod., 14, 1332, 10.1093\u002Fhumrep\u002F14.5.1332\nJacobson, 2002, Laparoscopic surgery for subfertility associated with endometriosis, Cochrane Database Syst. Rev., 10.1002\u002F14651858.CD001398\nKoninckx, 1996, Complications of CO2 laser endoscopic excision of deep endometriosis, Hum. Reprod., 11, 2263, 10.1093\u002Foxfordjournals.humrep.a019087\nDonnez, 1996, Large ovarian endometriomas, Hum. Reprod., 11, 641, 10.1093\u002FHUMREP\u002F11.3.641\nWyns, 2003, Vaporisation laser des endométriomes ovariens : impact sur la réponse aux gonadotrophines, Gynecol. Obstet. Fertil., 31, 337, 10.1016\u002FS1297-9589(03)00069-9\nCanis, 2001, Ovarian response during IVF-embryo transfer cycles after laparoscopic ovarian cystectomy for endometriotic cysts of > 3 cm in diameter, Hum. Reprod., 12, 2583, 10.1093\u002Fhumrep\u002F16.12.2583\nFernandez, 2003, La place du drilling ovarien dans la prise en charge du syndrome des ovaires polykystiques, Gynecol. Obstet. Fertil., 31, 207, 10.1016\u002FS1297-9589(03)00041-9\nMadelenat, 2003, Prises en charges alternatives du syndrome des OPK : contre le traitement chirurgical du syndrome des ovaires polykystiques, J Gynécol Obstét Biol Reprod, 32\nYuzpe, 1975, The value of laparoscopic ovarian biopsy, J. Reprod. Med., 15, 57\nGjonnaess, 1984, Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope, Fertil. Steril., 41, 20, 10.1016\u002FS0015-0282(16)47534-5\nDaniell, 1989, Polycystic ovaries treated by laparoscopic laser vaporization, Fertil. Steril., 51, 232, 10.1016\u002FS0015-0282(16)60482-X\nMerchant, 1996, Treatment of polycystic ovary disease with laparoscopic low-watt bipolar electrocoagulation of the ovaries, J. Am. Assoc. Gynecol. Laparosc., 3, 503, 10.1016\u002FS1074-3804(05)80158-6\nLi, 1998, Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian disease in women with anovulatory infertility, Br. J. Obstet. Gynaecol., 105, 338, 10.1111\u002Fj.1471-0528.1998.tb10097.x\nFarquhar, 2001, Laparoscopic \"drilling\" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome, Cochrane Database Syst. Rev., 10.1002\u002F14651858.CD001122\nBayram N, Van Wely M, Bossuyt P, Van der Veen F. Randomised clinical trial of laparoscopic electrocoagulation of the ovaries versus recombinant FSH for ovulation induction in subfertility associated with polycystic ovaries. Abstract O-148. 17th Annual Meeting of ESHRE, Lausanne, Switzerland, July 2001.\nFarquhar, 2002, A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotropin therapy for women with clomiphene citrate-resistant polycystic ovary syndrome, Fertil. Steril., 78, 404, 10.1016\u002FS0015-0282(02)03225-9\nLoffer, 1987, Hysteroscopic endometrial ablation with the Nd:YAG laser using a nontouch technique, Obstet. Gynecol., 69, 679\nGoldrath, 1981, Laser photovaporization of endometrium for the treatment of menorrhagia, Am. J. Obstet. Gynecol., 140, 14, 10.1016\u002F0002-9378(81)90251-9\nDeCherney, 1983, Hysteroscopic management of intrauterine lesions and intractable uterine bleeding, Obstet. Gynecol., 61, 392\nLin, 1988, The development of a new hysteroscopic resectoscope and its clinical applications on transcervical resection and endometrial ablation, Jpn J Gynecol Obstet Endosc, 4, 56, 10.5180\u002Fjsgoe.4.56\nVaincaillie, 1989, Electrocoagulation of the endometrium with the ball-ended resectoscope, Obstet. Gynecol., 74, 425\nLethaby, 2002, Endometrial destruction techniques for heavy menstrual bleeding, Cochrane Database Syst. Rev., 10.1002\u002F14651858.CD001501\nOverton, 1997, A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study, Br. J. Obstet. Gynaecol., 104, 1351, 10.1111\u002Fj.1471-0528.1997.tb11003.x\nBridgman, 1994, Increasing operative rates for dysfunctional uterine bleeding after endometrial ablation, Lancet, 344, 893, 10.1016\u002FS0140-6736(94)92868-1\nCoulter, 1994, Trends in gynaecological surgery, Lancet, 344, 1367, 10.1016\u002FS0140-6736(94)90727-7\nPitroff, 1993, Initial experience with transcervical cryoablation using saline as a uterine distension medium, Minimal Invas Ther, 2, 69, 10.3109\u002F13645709309152670\nBaggish, 1995, A computer-controlled, continuously circulating hot irrigating system for endometrial ablation, Am. J. Obstet. Gynecol., 173, 1842, 10.1016\u002F0002-9378(95)90438-7\nSharp, 1995, Microwaves for menorrhagia: a new fast technique for endometrial ablation, Lancet, 346, 1003, 10.1016\u002FS0140-6736(95)91689-X\nDonnez, 1996, endometrial laser interstitial hyperthermy: a potential modality for endometrial ablation, Obstet. Gynecol., 87, 459, 10.1016\u002F0029-7844(95)00412-2\nFehr, 1995, Intrauterine light delivery for photodynamic therapy of the human endometrium, Hum. Reprod., 10, 3067, 10.1093\u002Foxfordjournals.humrep.a135851\nSteiner, 1995, Rat reproductive performance following photodynamic therapy with topically administered Photofrin, Hum. Reprod., 10, 227, 10.1093\u002Fhumrep\u002F10.1.227\nWyss, 2003, Photodynamic endometrial ablation: morphological study, Lasers Surg. Med., 32, 305, 10.1002\u002Flsm.10163\nDegen, 2004, Photodynamic endometrial ablation for the treatment of dysfunctionnal uterine bleeding: a preliminary report, Lasers Surg. Med., 34, 1, 10.1002\u002Flsm.10244\nTadir, 1999, Intrauterine light probe for photodynamic ablation therapy, Obstet. Gynecol., 93, 299, 10.1097\u002F00006250-199902000-00027\nLethaby, 2005, Endometrial destruction techniques for heavy menstrual bleeding, Cochrane Database Syst. Rev., 10.1002\u002F14651858.CD001501.pub2\nJourdain, 1996, Endometrial Nd-YAG laser ablation by flexible hysteroscopy. Long-term follow-up of 137 cases, Eur. J. Obstet. Gynecol. Reprod. Biol., 69, 103, 10.1016\u002F0301-2115(95)02510-3\nHeinonen, 1997, Reproductive performance of women with uterine anomalies after abdominal or hysteroscopic metroplasty or no surgical treatment, J. Am. Assoc. Gynecol. Laparosc., 4, 311, 10.1016\u002FS1074-3804(05)80221-X\nVilos, 1999, Intrauterine surgery using a new coaxial bipolar electrode in normal saline solution (Versapoint®): a pilot study, Fertil. Steril., 72, 740\nBettochi, 2002, Advanced operative office hysteroscopy without anaesthesia: analysis of 501 cases treated with a 5 Fr. bipolar electrode, Hum. Reprod., 17, 2435, 10.1093\u002Fhumrep\u002F17.9.2435\nZikopoulos, 2004, Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint® system, Reprod. Biomed. Online, 8, 720, 10.1016\u002FS1472-6483(10)61654-9",{"ES":1016},"El láser en ginecología",{"VOID":1018},"10.1016\u002Fs1283-081x(08)70814-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X08708142",[1021,1036,1051,1063,1075,1087,1099],{"id":1022,"sortIndex":115,"researcher":26,"roles":1023,"affiliations":1024,"properties":1033},"f947abd2-8c63-45d5-a210-263ab2e0381a",[696],[1025],{"id":26,"sortIndex":36,"affiliation":1026,"properties":26},{"id":1027,"createTime":1028,"updateTime":1028,"relativeEntities":1029,"slug":26,"properties":1030,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8d42ea43-9289-4258-a323-078bf48f83e4","2024-02-10T01:05:26.313+00:00",[],{"title":1031},{"VI":1032},"Polyclinique Jean Villar, avenue Maryse-Bastié, 33520 Bordeaux-Bruges, France",{"title":1034},{"VI":1035},"E. Roussillon",{"id":1037,"sortIndex":59,"researcher":26,"roles":1038,"affiliations":1039,"properties":1048},"067c12fd-1f30-42b7-b004-b665e108e12b",[696],[1040],{"id":26,"sortIndex":36,"affiliation":1041,"properties":26},{"id":1042,"createTime":1043,"updateTime":1043,"relativeEntities":1044,"slug":26,"properties":1045,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8bbdfd7a-a191-4e57-8608-56385d5a9379","2024-02-10T01:05:26.338+00:00",[],{"title":1046},{"VI":1047},"Hôpital Saint-André, Centre hospitalier universitaire Bordeaux, 1, rue Jean-Burguet, 33000 Bordeaux, France",{"title":1049},{"VI":1050},"J. Versapuech",{"id":1052,"sortIndex":111,"researcher":26,"roles":1053,"affiliations":1054,"properties":1060},"3a0f9460-9e69-4f2d-8d73-5232c255beca",[696],[1055],{"id":26,"sortIndex":36,"affiliation":1056,"properties":26},{"id":1027,"createTime":1028,"updateTime":1028,"relativeEntities":1057,"slug":26,"properties":1058,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1059},{"VI":1032},{"title":1061},{"VI":1062},"M. Fontanges",{"id":1064,"sortIndex":135,"researcher":26,"roles":1065,"affiliations":1066,"properties":1072},"38d75d94-b2b1-40d1-a858-eab61a45650c",[696],[1067],{"id":26,"sortIndex":36,"affiliation":1068,"properties":26},{"id":1027,"createTime":1028,"updateTime":1028,"relativeEntities":1069,"slug":26,"properties":1070,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1071},{"VI":1032},{"title":1073},{"VI":1074},"J.-M. Gonnet",{"id":1076,"sortIndex":36,"researcher":26,"roles":1077,"affiliations":1078,"properties":1084},"9915c2a8-faa9-4fca-83cb-6208642db666",[696],[1079],{"id":26,"sortIndex":36,"affiliation":1080,"properties":26},{"id":1027,"createTime":1028,"updateTime":1028,"relativeEntities":1081,"slug":26,"properties":1082,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1083},{"VI":1032},{"title":1085},{"VI":1086},"O. Jourdain",{"id":1088,"sortIndex":114,"researcher":26,"roles":1089,"affiliations":1090,"properties":1096},"bae28a00-0caa-4691-9611-b34865645e58",[696],[1091],{"id":26,"sortIndex":36,"affiliation":1092,"properties":26},{"id":1027,"createTime":1028,"updateTime":1028,"relativeEntities":1093,"slug":26,"properties":1094,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1095},{"VI":1032},{"title":1097},{"VI":1098},"X. Lechat",{"id":1100,"sortIndex":162,"researcher":26,"roles":1101,"affiliations":1102,"properties":1108},"7046d4b9-7518-42f1-9e18-1f0730ceecda",[696],[1103],{"id":26,"sortIndex":36,"affiliation":1104,"properties":26},{"id":1027,"createTime":1028,"updateTime":1028,"relativeEntities":1105,"slug":26,"properties":1106,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1107},{"VI":1032},{"title":1109},{"VI":1110},"A. Schiano",{"url":1019,"publisher":1112,"properties":1120},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1113,"slug":662,"properties":1114,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1117,"manageAffiliations":1118,"indexDatabases":1119,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1115,"title":1116},{"VOID":665},{"EN":667},[],[],[],{"volume":1121,"pages":1123},{"VOID":1122},"44",{"VOID":1124},"1-10","2008-01-01",2008,{"id":1128,"createTime":1129,"updateTime":1130,"relativeEntities":1131,"slug":1132,"properties":1133,"entityType":688,"verifyStatus":25,"verifyTime":1130,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":1140,"fullTextUrl":26,"authors":1141,"publicationType":747,"publisherRelationship":1186,"citationCount":26,"citationInfo":26,"publishDate":1200,"publishYear":1201,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"2c592ca6-7d5a-401e-b3e8-a494c636687d","2024-01-13T06:01:35.723+00:00","2025-02-24T17:57:59.923+00:00",[],"Tratamiento-anticoagulante-durante-el-embarazo",{"references":1134,"title":1136,"doi":1138},{"VOID":1135},"Bourjeily, 2010, Pulmonary embolism in pregnancy, Lancet, 375, 500, 10.1016\u002FS0140-6736(09)60996-X\nMarik, 2008, Venous thromboembolic disease and pregnancy, N Engl J Med, 359, 2025, 10.1056\u002FNEJMra0707993\nAharon, 2011, Microparticles and pregnancy complications, Thromb Res, 127, S67, 10.1016\u002FS0049-3848(11)70019-6\nBates, 2012, VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, Chest, 141, 10.1378\u002Fchest.11-2300\nAbdul, 2015, Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study, BMJ Open, 5, 10\nMeng, 2015, Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis, J Matern Fetal Neonatal Med, 28, 245, 10.3109\u002F14767058.2014.913130\nAbdul, 2013, The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative meta-analysis, PLoS One, 8, 10\nAbdul, 2014, Impact of risk factors on the timing of first postpartum venous thromboembolism: a population-based cohort study from England, Blood, 124, 2872, 10.1182\u002Fblood-2014-05-572834\nKamel, 2014, Risk of a thrombotic event after the 6-week postpartum period, N Engl J Med, 370, 1307, 10.1056\u002FNEJMoa1311485\nJacobsen, 2008, Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study, J Thromb Haemost, 6, 905, 10.1111\u002Fj.1538-7836.2008.02961.x\nHeit, 2005, Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study, Ann Intern Med, 143, 697, 10.7326\u002F0003-4819-143-10-200511150-00006\nJacobsen, 2008, Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study, Am J Obstet Gynecol, 198, 10.1016\u002Fj.ajog.2007.08.041\nRay, 1999, Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation, Obstet Gynecol Surv, 54, 265, 10.1097\u002F00006254-199904000-00023\nSaucedo, 2013, Ten years of confidential inquiries into maternal deaths in France, 1998-2007, Obstet Gynecol, 122, 752, 10.1097\u002FAOG.0b013e31829fc38c\nPaidas, 2005, Inherited thrombophilias and adverse pregnancy outcome: screening and management, Semin Perinatol, 29, 150, 10.1053\u002Fj.semperi.2005.05.008\nDuley, 2007, Antiplatelet agents for preventing pre-eclampsia and its complications, Cochrane Database Syst Rev, CD004659\nSavitz, 2002, Epidemiologic measures of the course and outcome of pregnancy, Epidemiol Rev, 24, 91, 10.1093\u002Fepirev\u002Fmxf006\nGaudineau, 2013, Prevalence, risk factors, maternal and fetal morbidity and mortality of intrauterine growth restriction and small-for-gestational age, J Gynecol Obstet Biol Reprod, 42, 895, 10.1016\u002Fj.jgyn.2013.09.013\nRodger, 2008, Inherited thrombophilia and pregnancy complications revisited, Obstet Gynecol, 112, 320, 10.1097\u002FAOG.0b013e31817e8acc\nJames, 2006, Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality, Am J Obstet Gynecol, 194, 1311, 10.1016\u002Fj.ajog.2005.11.008\nMcColl, 1997, Risk factors for pregnancy associated venous thromboembolism, Thromb Haemost, 78, 1183, 10.1055\u002Fs-0038-1657712\nBates, 2008, Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 10.1378\u002Fchest.08-0761\nBates, 2007, Management of pregnant women with thrombophilia or a history of venous thromboembolism, Hematology Am Soc Hematol Educ Program, 2007, 143, 10.1182\u002Fasheducation-2007.1.143\nLindqvist, 2002, Individual risk assessment of thrombosis in pregnancy, Acta Obstet Gynecol Scand, 81, 412, 10.1034\u002Fj.1600-0412.2002.810507.x\nNoboa, 2008, Family history as a risk factor for venous thromboembolism, Thromb Res, 122, 624, 10.1016\u002Fj.thromres.2007.12.026\nEmmett, 2013, Risk factors for acute VTE in pregnancy and the postpartum period: a retrospective case control study of 14 years at National Women's Health, Auckland, New Zealand, J Thromb Haemost, 11, 221\nVirkus, 2014, Risk factors for venous thromboembolism in 1.3 million pregnancies: a nationwide prospective cohort, PLoS One, 9, e96495, 10.1371\u002Fjournal.pone.0096495\nRobertson, 2006, Thrombophilia in pregnancy: a systematic review, Br J Haematol, 132, 171, 10.1111\u002Fj.1365-2141.2005.05847.x\nGreer, 2003, Inherited thrombophilia and venous thromboembolism, Baillieres Best Pract Res Clin Obstet Gynaecol, 17, 413, 10.1016\u002FS1521-6934(03)00007-5\nNelson, 2006, Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium, Obstet Gynecol Clin North Am, 33, 413, 10.1016\u002Fj.ogc.2006.05.009\nRuiz-Irastorza, 2010, Antiphospholipid syndrome, Lancet, 376, 1498, 10.1016\u002FS0140-6736(10)60709-X\nLim, 2006, Management of antiphospholipid antibody syndrome: a systematic review, JAMA, 295, 1050, 10.1001\u002Fjama.295.9.1050\nGalli, 2003, Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome, Blood, 102, 2717, 10.1182\u002Fblood-2002-11-3334\nAnanth, 2007, Recurrence of ischemic placental disease, Obstet Gynecol, 110, 128, 10.1097\u002F01.AOG.0000266983.77458.71\nOdegård, 2000, Risk factors and clinical manifestations of pre-eclampsia, BJOG, 107, 1410, 10.1111\u002Fj.1471-0528.2000.tb11657.x\nMerviel, 2008, Risk factors of preeclampsia in single pregnancy, J Gynecol Obstet Biol Reprod, 37, 477, 10.1016\u002Fj.jgyn.2008.04.001\nGetahun, 2007, Risk factors for antepartum and intrapartum stillbirth: a population-based study, Am J Obstet Gynecol, 196, 499, 10.1016\u002Fj.ajog.2006.09.017\nNess, 2008, Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth, Am J Epidemiol, 168, 427, 10.1093\u002Faje\u002Fkwn140\nGalli, 2003, Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature, Blood, 101, 1827, 10.1182\u002Fblood-2002-02-0441\nRodger, 2010, The association of factor V Leyden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies, PLoS Med, 7, e1000292, 10.1371\u002Fjournal.pmed.1000292\nRodger, 2008, Inherited thrombophilia and pregnancy complications revisited, Obstet Gynecol, 112, 320, 10.1097\u002FAOG.0b013e31817e8acc\nHAS. http:\u002F\u002Fwww.has-sante.fr\u002Fportail\u002Fupload\u002Fdocs\u002Fapplication\u002Fpdf\u002F2010-12\u002Ffiche_de_bon_usage_-_compression_medicale_en_prevention_de_la_thrombose_veineuse.pdf.\nden Heijer, 2007, Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial, Blood, 109, 139, 10.1182\u002Fblood-2006-04-014654\nGreer, 2014, Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?, Br J Haematol, 165, 585, 10.1111\u002Fbjh.12813\nAskie, 2007, Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data, Lancet, 369, 1791, 10.1016\u002FS0140-6736(07)60712-0\nBujold, 2010, Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis, Obstet Gynecol, 116, 402, 10.1097\u002FAOG.0b013e3181e9322a\nButwick, 2010, Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs, Int J Obstet Anesth, 19, 193, 10.1016\u002Fj.ijoa.2009.06.008\nAndersen, 2010, Venous thromboembolism in pregnancy: prophylaxis and treatment with low molecular weight heparin, Acta Obstet Gynecol Scand, 89, 15, 10.3109\u002F00016340903370098\nGreer, 2006, Anticoagulants in pregnancy, J Thromb Thrombolysis, 21, 57, 10.1007\u002Fs11239-006-5578-5\nKeïta-Meyer, 2007, Analgesia in particular situation: pregnant woman, Ann Fr Anesth Reanim, 26, 1020, 10.1016\u002Fj.annfar.2007.08.009\nSaar, 2015, Diagnosis and management of acute pulmonary embolism: ESC guidelines 2014, Herz, 40, 1048, 10.1007\u002Fs00059-015-4378-0\nWesseling, 2001, Coumarins during pregnancy: long-term effects on growth and development of school-age children, Thromb Haemost, 85, 609, 10.1055\u002Fs-0037-1615641\nDe, 2015, Fondaparinux in pregnancy: could it be a safe option? A review of the literature, Thromb Res, 135, 1049, 10.1016\u002Fj.thromres.2015.04.001\nMagnani, 2010, An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran), Thromb Res, 125, 297, 10.1016\u002Fj.thromres.2009.06.006\nChapman, 2008, Lepirudin for treatment of acute thrombosis during pregnancy, Obstet Gynecol, 112, 432, 10.1097\u002FAOG.0b013e31817788e0\nConférence de consensus. Recommandations pour la pratique clinique de la Société française d’anesthésie et de réanimation : prévention de la maladie thromboembolique veineuse périopératoire et obstétricale. ANAES; 2005.\nSamama, 2006, Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines, Eur J Anaesthesiol, 23, 95, 10.1017\u002FS0265021505002164\nThromboembolic disease in pregnancy and the puerperium: acute management. Internet. Updated 2015; cited 3\u002F5\u002F2016. Available from: https:\u002F\u002Fwww.rcog.org.uk\u002Fglobalassets\u002Fdocuments\u002Fguidelines\u002Fgtg-37b.pdf.\nChauleur, 2008, Prophylaxis of thromboembolic disease in obstetrics after the French guidelines publication, Gynecol Obstet Fertil, 36, 23, 10.1016\u002Fj.gyobfe.2007.07.043\nMcLintock, 2012, Recommendations for the prevention of pregnancy-associated venous thromboembolism, Aust N Z J Obstet Gynaecol, 52, 3, 10.1111\u002Fj.1479-828X.2011.01357.x\nDargaud, 2009, A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study, Br J Haematol, 145, 825, 10.1111\u002Fj.1365-2141.2009.07698.x\nChauleur, 2010, Use of the Delphi method to facilitate antithrombotics prescription during pregnancy, Thromb Res, 126, 88, 10.1016\u002Fj.thromres.2010.01.012\nTesta, 2015, The “Pregnancy Health-care Program” for the prevention of venous thromboembolism in pregnancy, Intern Emerg Med, 10, 129, 10.1007\u002Fs11739-014-1111-6\nSarig, 2009, Assessment and management of high-risk pregnancies in women with thrombophilia, Blood Rev, 23, 143, 10.1016\u002Fj.blre.2008.11.001\nBauersachs, 2007, Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women, Thromb Haemost, 98, 1237, 10.1160\u002FTH07-05-0329\nRodger, 2014, Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial, Lancet, 384, 1673, 10.1016\u002FS0140-6736(14)60793-5",{"ES":1137},"Tratamiento anticoagulante durante el embarazo",{"VOID":1139},"10.1016\u002Fs1283-081x(17)85966-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X1785966X",[1142,1167],{"id":1143,"sortIndex":36,"researcher":26,"roles":1144,"affiliations":1145,"properties":1164},"39dd3a95-9fe6-4049-990a-d4ec41b7164d",[696],[1146,1154],{"id":26,"sortIndex":36,"affiliation":1147,"properties":26},{"id":1148,"createTime":1149,"updateTime":1149,"relativeEntities":1150,"slug":26,"properties":1151,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"497b037f-6e25-4fe5-9fe7-df70f6a28b05","2024-01-13T06:01:35.764+00:00",[],{"title":1152},{"VI":1153},"Inserm, U1059, Pôle santé, CHU de Saint-Étienne, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France",{"id":1155,"sortIndex":115,"affiliation":1156,"properties":1163},"51ae8b7d-3f15-4414-b844-8aec3dd0af3d",{"id":1157,"createTime":1158,"updateTime":1158,"relativeEntities":1159,"slug":26,"properties":1160,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"f51d5120-c8ee-4011-a55b-c88674f5b178","2024-01-13T06:01:35.768+00:00",[],{"title":1161},{"VI":1162},"Département de gynécologie-obstétrique, Hôpital Nord, CHU de Saint-Étienne, avenue Albert-Raimond, 42270 Saint-Priest-en-Jarez, France",{},{"title":1165},{"VI":1166},"C. Chauleur",{"id":1168,"sortIndex":115,"researcher":26,"roles":1169,"affiliations":1170,"properties":1183},"b287fe5a-b3c6-454c-ae30-274ea743c2f2",[696],[1171,1178],{"id":1172,"sortIndex":115,"affiliation":1173,"properties":1177},"83866648-c59d-4e9d-885a-e64a568ea620",{"id":1157,"createTime":1158,"updateTime":1158,"relativeEntities":1174,"slug":26,"properties":1175,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1176},{"VI":1162},{},{"id":26,"sortIndex":36,"affiliation":1179,"properties":26},{"id":1148,"createTime":1149,"updateTime":1149,"relativeEntities":1180,"slug":26,"properties":1181,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1182},{"VI":1153},{"title":1184},{"VI":1185},"T. Raia-Barjat",{"url":1140,"publisher":1187,"properties":1195},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1188,"slug":662,"properties":1189,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1192,"manageAffiliations":1193,"indexDatabases":1194,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1190,"title":1191},{"VOID":665},{"EN":667},[],[],[],{"volume":1196,"pages":1198},{"VOID":1197},"53",{"VOID":1199},"1-8","2017-09-01",2017,{"id":1203,"createTime":1204,"updateTime":1205,"relativeEntities":1206,"slug":1207,"properties":1208,"entityType":688,"verifyStatus":25,"verifyTime":1205,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1215,"fullTextUrl":26,"authors":1216,"publicationType":747,"publisherRelationship":1259,"citationCount":26,"citationInfo":26,"publishDate":1273,"publishYear":1274,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"465c13cb-10f0-48fe-b473-9d044a34aef1","2023-12-25T16:43:37.648+00:00","2025-02-25T13:49:49.872+00:00",[],"T%C3%A9cnicas-de-extracci%C3%B3n-de-muestras-fetales",{"references":1209,"title":1211,"doi":1213},{"VOID":1210},"Nicolaides, 1994, Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks’ gestation, Lancet, 344, 435, 10.1016\u002FS0140-6736(94)91769-8\nSundberg, 1997, Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus sampling, Lancet, 350, 697, 10.1016\u002FS0140-6736(97)02449-5\nThe Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group, 1998, Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis, Lancet, 351, 242, 10.1016\u002FS0140-6736(97)12346-7\nAlfirevic, 2003, Amniocentesis and chorionic villus sampling for prenatal diagnosis, Cochrane Database Syst Rev, CD003252\nTabor, 1986, Randomised controlled trial of genetic amniocentesis in 4606 low-risk women, Lancet, 1, 1287, 10.1016\u002FS0140-6736(86)91218-3\nTabor, 2010, Update on procedure-related risks for prenatal diagnosis techniques, Fetal Diagn Ther, 27, 1, 10.1159\u002F000271995\nEddleman, 2006, Pregnancy loss rates after midtrimester amniocentesis, Obstet Gynecol, 108, 1067, 10.1097\u002F01.AOG.0000240135.13594.07\nMalan, 2018, Effect of cell-free DNA screening vs direct invasive diagnosis on miscarriage rates in women with pregnancies at high risk of trisomy 21: a randomized clinical trial, JAMA, 320, 557, 10.1001\u002Fjama.2018.9396\nSalomon, 2019, Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis, Ultrasound Obstet Gynecol, 54, 442, 10.1002\u002Fuog.20353\nPapantoniou, 2001, Risk factors predisposing to fetal loss following a second trimester amniocentesis, BJOG, 108, 1053\nD’Alton, 1994, Prenatal diagnostic procedures, Semin Perinatol, 18, 140\nGentilin, 2008, Discordant prenatal phenotype and karyotype of monozygotic twins characterized by the unequal distribution of two cell lines investigated by different methods: a review, Twin Res Hum Genet, 11, 352, 10.1375\u002Ftwin.11.3.352\nSperling, 2019, Pregnancy loss after amniocentesis in monochorionic and dichorionic twin pregnancies: results from a large population-based dataset, Prenat Diagn, 39, 896, 10.1002\u002Fpd.5502\nDi Mascio, 2020, Risk of fetal loss following amniocentesis or chorionic villus sampling in twin pregnancy: systematic review and meta-analysis, Ultrasound Obstet Gynecol, 56, 647, 10.1002\u002Fuog.22143\nMastroiacovo, 1991, Limb-reduction defects and chorion villus sampling, Lancet, 337, 1091, 10.1016\u002F0140-6736(91)91735-D\nBurton, 1992, Limb anomalies associated with chorionic villus sampling, Obstet Gynecol, 79, 726\nKuliev, 1993, Risk evaluation of CVS, Prenat Diagn, 13, 197, 10.1002\u002Fpd.1970130307\nFirth, 1994, Analysis of limb reduction defects in babies exposed to chorionic villus sampling, Lancet, 343, 1069, 10.1016\u002FS0140-6736(94)90182-1\nBrun, 2003, Feasibility, accuracy and safety of chorionic villus sampling: a report of 10741 cases, Prenat Diagn, 23, 295, 10.1002\u002Fpd.578\nMujezinovic, 2007, Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review, Obstet Gynecol, 110, 687, 10.1097\u002F01.AOG.0000278820.54029.e3\nGrobman, 2009, The association between chorionic villus sampling and preeclampsia, Prenat Diagn, 29, 800, 10.1002\u002Fpd.2296\nDias, 2011, First-trimester ultrasound determination of chorionicity in twin pregnancy, Ultrasound Obstet Gynecol, 38, 530, 10.1002\u002Fuog.8956\nWeisz, 2005, Invasive diagnostic procedures in twin pregnancies, Prenat Diagn, 25, 751, 10.1002\u002Fpd.1263\nRochon, 2003, Invasive procedures in multiple gestations, Curr Opin Obstet Gynecol, 15, 167, 10.1097\u002F00001703-200304000-00012\nCasals, 2002, Transcervical chorionic villus sampling in multiple pregnancies using a biopsy forceps, Prenat Diagn, 22, 260, 10.1002\u002Fpd.315\nSilver, 1998, Midtrimester amniocentesis. Influence of operator caseload on sampling efficiency, J Reprod Med, 43, 191\nWijnberger, 2000, Learning in medicine: chorionic villus sampling, Prenat Diagn, 20, 241, 10.1002\u002F(SICI)1097-0223(200003)20:3\u003C241::AID-PD793>3.0.CO;2-X\nHobbins, 1974, New method of intrauterine evaluation by the combined use of fetoscopy and ultrasound, Am J Obstet Gynecol, 118, 1069, 10.1016\u002F0002-9378(74)90684-X\nValenti, 1973, Antenatal detection of hemoglobinopathies. A preliminary report, Am J Obstet Gynecol, 115, 851, 10.1016\u002F0002-9378(73)90532-2\nDaffos, 1983, Fetal blood sampling via the umbilical cord using a needle guided by ultrasound. Report of 66 cases, Prenat Diagn, 3, 271, 10.1002\u002Fpd.1970030402\nWeiner, 1987, Cordocentesis for diagnostic indications: two years’ experience, Obstet Gynecol, 70, 664\nWeiner, 1991, Risk factors for cordocentesis and fetal intravascular transfusion, Am J Obstet Gynecol, 165, 1020, 10.1016\u002F0002-9378(91)90462-Z\nCordier, 2016, Teaching invasive prenatal procedures: effectiveness of two simple simulators in training, Prenat Diagn, 36, 905, 10.1002\u002Fpd.4875",{"ES":1212},"Técnicas de extracción de muestras fetales",{"VOID":1214},"10.1016\u002Fs1283-081x(22)46052-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22460528",[1217,1232,1247],{"id":1218,"sortIndex":115,"researcher":26,"roles":1219,"affiliations":1220,"properties":1229},"826e5ed4-a97a-48fe-af0d-77e00d219faa",[696],[1221],{"id":26,"sortIndex":36,"affiliation":1222,"properties":26},{"id":1223,"createTime":1224,"updateTime":1224,"relativeEntities":1225,"slug":26,"properties":1226,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"653f051f-d2d5-4107-bb39-871d5a2c2a46","2023-12-25T16:43:37.701+00:00",[],{"title":1227},{"VI":1228},"Maternité, Hôpital Necker, 149, rue de Sèvres, 75015 Paris, France",{"title":1230},{"VI":1231},"C. Colmant",{"id":1233,"sortIndex":114,"researcher":26,"roles":1234,"affiliations":1235,"properties":1244},"9ab8514c-2a4e-4d4d-b777-5b8093ea6f44",[696],[1236],{"id":26,"sortIndex":36,"affiliation":1237,"properties":26},{"id":1238,"createTime":1239,"updateTime":1239,"relativeEntities":1240,"slug":26,"properties":1241,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6f9894a4-a71d-40e9-90cd-33bb0280b154","2023-12-25T16:43:37.728+00:00",[],{"title":1242},{"VI":1243},"Maternité-Hôpital du Kremlin-Bicêtre, 78, rue du Général-Leclerc, 94250 Le Kremlin-Bicêtre, France",{"title":1245},{"VI":1246},"M.-V. Senat",{"id":1248,"sortIndex":36,"researcher":26,"roles":1249,"affiliations":1250,"properties":1256},"c8e4bdaf-03ae-40e8-8212-e3f00dc89b8e",[696],[1251],{"id":26,"sortIndex":36,"affiliation":1252,"properties":26},{"id":1238,"createTime":1239,"updateTime":1239,"relativeEntities":1253,"slug":26,"properties":1254,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1255},{"VI":1243},{"title":1257},{"VI":1258},"G. Dumery",{"url":1215,"publisher":1260,"properties":1268},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1261,"slug":662,"properties":1262,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1265,"manageAffiliations":1266,"indexDatabases":1267,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1263,"title":1264},{"VOID":665},{"EN":667},[],[],[],{"volume":1269,"pages":1271},{"VOID":1270},"58",{"VOID":1272},"1-7","2022-03-01",2022,{"id":1276,"createTime":1277,"updateTime":1277,"relativeEntities":1278,"slug":26,"properties":1279,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1286,"fullTextUrl":26,"authors":1287,"publicationType":747,"publisherRelationship":1295,"citationCount":26,"citationInfo":26,"publishDate":973,"publishYear":974,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"31a7f9d6-93d1-402c-be84-14a37a565937","2023-12-12T01:24:20.491+00:00",[],{"references":1280,"title":1282,"doi":1284},{"VOID":1281},"Lacroix, 2000, Prescription of drugs during pregnancy in France, Lancet, 356, 1735, 10.1016\u002FS0140-6736(00)03209-8\nGarcia, 2000, Prescription médicamenteuse chez la femme enceinte dans le département de la Loire, Therapie, 55, 605\nBeyens, 2003, Prescription of drugs to pregnant women in France: the HIMAGE study, Therapie, 58, 505, 10.2515\u002Ftherapie:2003082\nOlesen, 2006, Associations between socio-economic factors and the use of prescription medication during pregnancy: a population-based study among 19,874 Danish women, Eur. J. Clin. Pharmacol., 62, 547, 10.1007\u002Fs00228-006-0119-x\nEgen-Lappe, 2004, Drug prescription in pregnancy: analysis of a large statutory sickness fund population, Eur. J. Clin. Pharmacol., 60, 659, 10.1007\u002Fs00228-004-0817-1\nAndrade, 2004, Prescription drug use in pregnancy, Am. J. Obstet. Gynecol., 191, 398, 10.1016\u002Fj.ajog.2004.04.025\nLee, 2006, National patterns of medication use during pregnancy, Pharmacoepidemiol. Drug Saf., 15, 537, 10.1002\u002Fpds.1241\nMattison, 2006, Gaps in knowledge in treating pregnant women, Gend Med, 3, 169, 10.1016\u002FS1550-8579(06)80205-6\nGlover, 2003, Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population, Am. J. Obstet. Gynecol., 188, 1039, 10.1067\u002Fmob.2003.223\nNordeng, 2004, Use of herbal drugs in pregnancy: A survey among 400 Norwegian women, Pharmacoepidemiol Drug Sail, 13, 371, 10.1002\u002Fpds.945\nSchirm, 2004, Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system, Eur. J. Obstet. Gynecol. Reprod. Biol., 114, 182, 10.1016\u002Fj.ejogrb.2003.10.024\nHeadley, 2004, Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children, Eur. J. Clin. Pharmacol., 60, 355, 10.1007\u002Fs00228-004-0775-7\nCzeizel, 2009, The estimation of human teratogenic\u002Ffetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology, Expert Opin. Drug Saf., 8, 283, 10.1517\u002F14740330902916459\nBuhimschi, 2009, Medications in pregnancy and lactation: part 1. Teratology, Obstet. Gynecol., 113, 166, 10.1097\u002FAOG.0b013e31818d6788\nAugustine-Rauch, 2007, Alternative experimental approaches for interpreting skeletal findings in safety studies, Birth Defects Res B Dev Reprod Toxicol, 80, 497, 10.1002\u002Fbdrb.20132\nAugustine-Rauch, 2008, Predictive teratology: teratogenic risk-hazard identification partnered in the discovery process, Curr. Drug Metab., 9, 971, 10.2174\u002F138920008786485137\nMohan, 2007, Computer-assisted methods in chemical toxicity prediction, Mini Rev. Med. Chem., 7, 499, 10.2174\u002F138955707780619554\nØstensen, 2009, Management of RA medications in pregnant patients, Nat Rev Rheumatol, 5, 382, 10.1038\u002Fnrrheum.2009.103\nMir, 2010, Taxanes for breast cancer during pregnancy: a systematic review, Ann. Oncol., 21, 425, 10.1093\u002Fannonc\u002Fmdp517\nMawer, 2010, Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study, Seizure, 19, 112, 10.1016\u002Fj.seizure.2009.11.008\n2007, Prakash, Prabhu LV, Nasar MA, Rai R, Madhyastha S, Singh G. Lamotrigine in pregnancy: safety profile and the risk of malformations, Singapore Med. J., 48, 880\nNguyen, 2009, Teratogenesis associated with antibipolar agents, Adv. Ther., 26, 281, 10.1007\u002Fs12325-009-0011-z\nSerreau, 2006, Placental transfer of drugs, 285\nJacqz Aigrain E, Serreau R. Pharmacologie fœto-maternelle : risques des médicaments en cours de grossesse, traitements médicamenteux du fœtus. EMC (Elsevier Masson SAS, Paris), Pédiatrie, 4-002-M-10, 2002 : 7p.\nMenon, 2008, Psychotropic medication during pregnancy and lactation, Arch. Gynecol. Obstet., 277, 1, 10.1007\u002Fs00404-007-0433-2\nWatts, 2007, Teratogenicity risk of antiretroviral therapy in pregnancy, Curr HIV\u002FAIDS Rep, 4, 135, 10.1007\u002Fs11904-007-0020-y\nSoldin, 2008, Triptans in pregnancy, Ther. Drug Monit., 30, 5, 10.1097\u002FFTD.0b013e318162c89b\nKlieger, 2008, Treating the mother--protecting the unborn: the safety of hypoglycemic drugs in pregnancy, J. Matern. Fetal Neonatal Med., 21, 191, 10.1080\u002F14767050801929653\nMir, 2008, Use of platinum derivatives during pregnancy, Cancer, 113, 3069, 10.1002\u002Fcncr.23935\nSchinkel, 1997, The physiological function of drug-transporting pglycoproteins, Semin. Cancer Biol., 8, 161, 10.1006\u002Fscbi.1997.0068\nTanabe, 2001, Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene, J. Pharmacol. Exp. Ther., 297, 1137\nLankas, 1997, P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances vermectin induced neurotoxicity, Toxicol. Appl. Pharmacol., 143, 357, 10.1006\u002Ftaap.1996.8086\nMolsa, 2005, Functional role of P-glycoprotein in the human blood-placental barrier, Clin. Pharmacol. Ther., 78, 123, 10.1016\u002Fj.clpt.2005.04.014\nSmit, 1999, Absence or pharmacological blocking of placental Pglycoprotein profoundly increases fetal drug exposure, J. Clin. Invest., 104, 1441, 10.1172\u002FJCI7963\nAtkinson, 2003, Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer, Am. J. Physiol. Cell Physiol., 285, C584, 10.1152\u002Fajpcell.00418.2002\nNagashige, 2003, Basal membrane localization of MRP1 in human placental trophoblast, Placenta, 24, 951, 10.1016\u002FS0143-4004(03)00170-X\nHooijberg, 2004, Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1), Biochem. Pharmacol., 67, 1541, 10.1016\u002Fj.bcp.2003.12.022\nIfergan, 2004, Folate deprivation results in the loss of breast cancer resistance protein (BCRP\u002FABCG2) expression: a role for BCRP in cellular folate homeostasis, J. Biol. Chem., 279, 25527, 10.1074\u002Fjbc.M401725200\nGennuso, 2004, Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1), Proc. Natl. Acad. Sci. USA, 101, 2470, 10.1073\u002Fpnas.0308452100\nMadon, 2000, Transport function and hepatocellular localization of mrp6 in rat liver, Mol. Pharmacol., 57, 634, 10.1124\u002Fmol.57.3.634\nSt-Pierre, 2000, Expression of members of the multidrug resistance protein family in human term placenta, Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, R1495, 10.1152\u002Fajpregu.2000.279.4.R1495\nGunshin, 1997, Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature, 388, 482, 10.1038\u002F41343\nAllikmets, 1998, A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance, Cancer Res., 58, 5337\nMiyake, 1998, Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone- resistant cells: 7 breast cancer cells, Proc. Natl. Acad. Sci. USA, 95, 15665\nAFSSAPS. Rappel sur la contre-indication des antagonistes des récepteurs à l'angiotensine II au cours des 2es et 3es trimestres de grossesse, lettre aux prescripteurs, juin 2003, agmed.sante.gouv.fr\u002Fhtm\u002F10\u002Ffilltrpsc\u002Flp030602.htm.\nSerreau, 1999, Developmental toxicity of the angiotensine II type 1 receptor antagonists human demonstration of homology to ABC transport genes, Cancer Res., 59, 8\nDoyle, 2005, A multidrug resistance transporter from human MCF- pregnancy a report of 10 cases, BJOG, 112, 710\nMartinovic, 2001, Fetal toxic effects and angiotensin-II-receptor antagonists, Lancet, 358, 241, 10.1016\u002FS0140-6736(01)05426-5\nRamasubbu, 2004, Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review, J. Clin. Psychiatry, 65, 1642, 10.4088\u002FJCP.v65n1209\nGuittin, 2002, Future improvements and implementation of animal care practices within the animal testing regulatory environment, ILAR J., 43, S80, 10.1093\u002Filar.43.Suppl_1.S80\n2005, Prescrire. « Éviter les rétinoïdes en application cutanée pendant la grossesse, Rev Prescrire, 25, 106\nRecommandations médicaments et grossesse du dictionnaire Vidal® (accès libre ; mise à jour : 12 novembre 2009) avec les références et sites internationaux ; arbre décisionnel.\nwww.vidalrecos.fr\u002Fpages\u002Findex.php?idannexe=2585&titre=Prescription_et_populations_particulieres_Medicaments_et_grossesse&prov=acc.\nAfssaps – octobre 2009 – actualité thalidomide et plan de gestion de risque www.afssaps.fr\u002Fvar\u002Fafssaps_site\u002Fstorage\u002Foriginal\u002Fapplication\u002F47fdcdc60cd555fe67ba5ba652a36495.pdf.\nCentre de références sur les agents tératogènes (CRAT) www.lecrat.org\u002F.\nIconographie d'un hypocalvaria fœtal après une exposition in utero aux IEC : http:\u002F\u002Fjasn.asnjournals.org\u002Fcgi\u002Freprint\u002F3\u002F9\u002F1575.\nDysgénésie rénale après exposition IEC ou sartans : www.humpath.com\u002Frenal-tubular-dysgenesis.",{"ES":1283},"Teratología y uso de medicamentos durante el embarazo",{"VOID":1285},"10.1016\u002Fs1283-081x(11)71084-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X11710840",[1288],{"id":1289,"sortIndex":36,"researcher":26,"roles":1290,"affiliations":1291,"properties":1292},"1a90059d-f00e-4d93-b772-61e905070016",[696],[],{"title":1293},{"VI":1294},"R. Serreau",{"url":1286,"publisher":1296,"properties":1304},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1297,"slug":662,"properties":1298,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1301,"manageAffiliations":1302,"indexDatabases":1303,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1299,"title":1300},{"VOID":665},{"EN":667},[],[],[],{"volume":1305,"pages":1306},{"VOID":970},{"VOID":1124},{"id":1308,"createTime":1309,"updateTime":1309,"relativeEntities":1310,"slug":26,"properties":1311,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1318,"fullTextUrl":26,"authors":1319,"publicationType":747,"publisherRelationship":1364,"citationCount":26,"citationInfo":26,"publishDate":1377,"publishYear":1201,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e4308196-8b54-4ef9-bf1b-8a23a1db9d49","2024-01-16T20:43:54.903+00:00",[],{"references":1312,"title":1314,"doi":1316},{"VOID":1313},"Fritsch, 1894, Ein Fall von volligem Schwaund der Gebormutterhohle nach, Auskratzung Zentralbl Gynaekol, 18, 1337\nBass, 1927, Ueber die Verwachsungen in der cervix uteri nach curettagen, Zentralbl Gynaekol, 51, 223\nStamer, 1946, Partial and total atresia of the uterus after excochleation, Acta Obstet Gynececol Scand, 26, 263, 10.3109\u002F00016344609154456\nAsherman, 1950, Traumatic intra-uterine adhesions, J Obstet Gynaecol Br Emp, 57, 892, 10.1111\u002Fj.1471-0528.1950.tb06053.x\nAsherman, 1948, Amenorrhoea traumatica (atretica), J Obstet Gynaecol Br Emp, 55, 23, 10.1111\u002Fj.1471-0528.1948.tb07045.x\nAsherman, 1958, Uterine adhesions, Harefuah, 55, 138\nAsherman, 1952, Intrauterine adhesions, Bull Fed Soc Gynecol Obstet Lang Fr, 4, 807\nYu, 2008, Asherman syndrome--one century later, Fertil Steril, 89, 759, 10.1016\u002Fj.fertnstert.2008.02.096\nLevine, 1972, Evaluation of a method of hysteroscopy with the use of thirty per cent Dextran, Am J Obstet Gynecol, 113, 696, 10.1016\u002F0002-9378(72)90641-2\nHamou, 1981, Microhysteroscopy. A new procedure and its original applications in gynecology, J Reprod Med, 26, 375\nSchenker, 1982, Intrauterine adhesions: an updated appraisal, Fertil Steril, 37, 593, 10.1016\u002FS0015-0282(16)46268-0\nSoares, 2000, Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases, Fertil Steril, 73, 406, 10.1016\u002FS0015-0282(99)00532-4\nMarch, 1978, Hysteroscopic management of intrauterine adhesions, Am J Obstet Gynecol, 130, 653, 10.1016\u002F0002-9378(78)90322-8\nThe American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions. Fertil Steril 1988;49:944–55.\nWamsteker, 1995, Diagnostic hysteroscopy: technique and documentation, Endosc Surg Gynecol, 1995, 263\nHooker, 2014, Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome, Hum Reprod Update, 20, 262, 10.1093\u002Fhumupd\u002Fdmt045\nGolan, 1992, Hysteroscopic findings after missed abortion, Fertil Steril, 58, 508, 10.1016\u002FS0015-0282(16)55253-4\nFriedler, 1993, Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy--a prospective study, Hum Reprod, 8, 442, 10.1093\u002Foxfordjournals.humrep.a138068\nRomer, 1996, [Early diagnosis of congenital and acquired intrauterine causes of abortion by post-abortion hysteroscopy], Geburtshilfe Frauenheilkd, 56, 542\nRomer, 1994, Post-abortion-hysteroscopy--a method for early diagnosis of congenital and acquired intrauterine causes of abortions, Eur J Obstet Gynecol Reprod Biol, 57, 171, 10.1016\u002F0028-2243(94)90295-X\nYasar, 2004, Prophylactic estrogen administration for preventing intrauterine adhesion formation following missed abortions, Jinekoloji ve Obstetrik Dergisi, 2004, 154\nSalzani, 2007, Prevalence of uterine synechia after abortion evacuation curettage, Sao Paulo Med J, 125, 261, 10.1590\u002FS1516-31802007000500002\nKuzel, 2011, “See and treat” hysteroscopy after missed abortion, Minim Invasive Ther Allied Technol, 20, 14, 10.3109\u002F13645706.2010.496999\nCogendez, 2011, Post-abortion hysteroscopy: a method for early diagnosis of congenital and acquired intrauterine causes of abortions, Eur J Obstet Gynecol Reprod Biol, 156, 101, 10.1016\u002Fj.ejogrb.2010.12.025\nWestendorp, 1998, Prevalence of Asherman's syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion, Hum Reprod, 13, 3347, 10.1093\u002Fhumrep\u002F13.12.3347\nSentilhes, 2014, Postpartum hemorrhage: guidelines for clinical practice - Text of the guidelines (short text), J Gynecol Obstet Biol Reprod, 43, 1170, 10.1016\u002Fj.jgyn.2014.10.009\nJamard, 2014, Risk of uterine synechiae following uterine compression sutures during postpartum haemorrhage, Gynecol Obstet Fertil, 42, 681, 10.1016\u002Fj.gyobfe.2014.04.013\nDesbriere, 2008, Hemostatic multiple square suturing is an effective treatment for the surgical management of intractable obstetric hemorrhage, Eur J Obstet Gynecol Reprod Biol, 138, 244, 10.1016\u002Fj.ejogrb.2007.03.017\nPoujade, 2011, Risk of synechiae following uterine compression sutures in the management of major postpartum haemorrhage, BJOG, 118, 433, 10.1111\u002Fj.1471-0528.2010.02817.x\nRasheed, 2014, Reproductive performance after conservative surgical treatment of postpartum hemorrhage, Int J Gynaecol Obstet, 124, 248, 10.1016\u002Fj.ijgo.2013.08.018\nIbrahim, 2013, Risk of postpartum uterine synechiae following uterine compression suturing during postpartum haemorrhage, Aust N Z J Obstet Gynaecol, 53, 37, 10.1111\u002Fajo.12017\nGambadauro, 2012, Intrauterine adhesions following conservative treatment of uterine fibroids, Obstet Gynecol Int, 2012, 853269, 10.1155\u002F2012\u002F853269\nTaskin, 2000, Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery, J Am Assoc Gynecol Laparosc, 7, 351, 10.1016\u002FS1074-3804(05)60478-1\nYang, 2008, Office hysteroscopic early lysis of intrauterine adhesion after transcervical resection of multiple apposing submucous myomas, Fertil Steril, 89, 1254, 10.1016\u002Fj.fertnstert.2007.05.027\nRoy, 2010, Reproductive outcome following hysteroscopic myomectomy in patients with infertility and recurrent abortions, Arch Gynecol Obstet, 282, 553, 10.1007\u002Fs00404-010-1531-0\nGuida, 2004, Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study, Hum Reprod, 19, 1461, 10.1093\u002Fhumrep\u002Fdeh238\nMazzon, 2014, Does cold loop hysteroscopic myomectomy reduce intrauterine adhesions?. A retrospective study, Fertil Steril, 101, 10.1016\u002Fj.fertnstert.2013.09.032\nTouboul, 2009, Uterine synechiae after bipolar hysteroscopic resection of submucosal myomas in patients with infertility, Fertil Steril, 92, 1690, 10.1016\u002Fj.fertnstert.2008.08.108\nDarwish, 2010, Biological effects of distension media in bipolar versus monopolar resectoscopic myomectomy: a randomized trial, J Obstet Gynaecol Res, 36, 810, 10.1111\u002Fj.1447-0756.2010.01244.x\nDubuisson, 2011, Hysteroscopic myomectomy using bipolar energy: a gold standard?, J Gynecol Obstet Biol Reprod, 40, 291, 10.1016\u002Fj.jgyn.2011.01.011\nRamirez-Sanchez, 2015, Intrauterine synechiae after use of monopolar resectoscope, Ginecol Obstet Mex, 83, 340\nLudwin, 2014, Role of morphologic characteristics of the uterine septum in the prediction and prevention of abnormal healing outcomes after hysteroscopic metroplasty, Hum Reprod, 29, 1420, 10.1093\u002Fhumrep\u002Fdeu110\nGoldenberg, 1997, Managing residual trophoblastic tissue. Hysteroscopy for directing curettage, J Reprod Med, 42, 26\nFaivre, 2009, Hysteroscopic management of residual trophoblastic tissue and reproductive outcome: a pilot study, J Minim Invasive Gynecol, 16, 487, 10.1016\u002Fj.jmig.2009.04.011\nGolan, 2011, Operative hysteroscopy to remove retained products of conception: novel treatment of an old problem, J Minim Invasive Gynecol, 18, 100, 10.1016\u002Fj.jmig.2010.09.001\nRein, 2011, Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage, J Minim Invasive Gynecol, 18, 774, 10.1016\u002Fj.jmig.2011.08.003\nBen-Ami, 2014, A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception, Int J Gynaecol Obstet, 127, 86, 10.1016\u002Fj.ijgo.2014.05.003\nCNGOF, 2011, Update of myoma management: guidelines for clinical practice - text of the guidelines, J Gynecol Obstet Biol Reprod, 40, 953\nMara, 2012, Hysteroscopy after uterine fibroid embolization: evaluation of intrauterine findings in 127 patients, J Obstet Gynaecol Res, 38, 823, 10.1111\u002Fj.1447-0756.2011.01782.x\nSong, 2014, A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman's syndrome after uterine artery embolization or surgical trauma, J Minim Invasive Gynecol, 21, 1022, 10.1016\u002Fj.jmig.2014.04.015\nNetter, 1955, Tuberculous endo-uterine symphysis; an anatomo-clinical and radiologically characteristic syndrome, Gynecol Obstet, 54, 19\nSharma, 2008, Hysterosalpingographic findings in infertile women with genital tuberculosis, Int J Gynaecol Obstet, 101, 150, 10.1016\u002Fj.ijgo.2007.11.006\nChavhan, 2004, Female genital tuberculosis: hysterosalpingographic appearances, Br J Radiol, 77, 164, 10.1259\u002Fbjr\u002F27379200\nBosteels, 2010, The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review, Hum Reprod Update, 16, 1, 10.1093\u002Fhumupd\u002Fdmp033\nPiketty, 2010, Surgical management of intrauterine adhesions: is benefice bigger than risk?, Gynecol Obstet Fertil, 38, 547, 10.1016\u002Fj.gyobfe.2010.07.005\nFrench College of Gynecologists and Obstetricians, 2013, Prevention of the complications related to hysteroscopy: text of guidelines for clinical practice--Synthesis, J Gynecol Obstet Biol Reprod, 42, 1050\nFedele, 1986, Intrauterine adhesions: current diagnostic and therapeutic trends, Acta Eur Fertil, 17, 31\nFernandez, 2012, Total adhesions treated by hysteroscopy: must we stop at two procedures?, Fertil Steril, 98, 980, 10.1016\u002Fj.fertnstert.2012.06.032\nHanstede, 2015, Results of centralized Asherman surgery, 2003-2013, Fertil Steril, 104, 10.1016\u002Fj.fertnstert.2015.08.039\nLitta, 2004, Hysteroscopic metroplasty under laparoscopic guidance in infertile women with septate uteri: follow-up of reproductive outcome, J Reprod Med, 49, 274\nKresowik, 2012, Ultrasound is the optimal choice for guidance in difficult hysteroscopy, Ultrasound Obstet Gynecol, 39, 715, 10.1002\u002Fuog.11072\nShalev, 1986, Operative hysteroscopy under real-time ultrasonography, Am J Obstet Gynecol, 155, 1360, 10.1016\u002F0002-9378(86)90180-8\nShalev, 1994, Ultrasound controlled operative hysteroscopy, J Am Coll Surg, 179, 70\nValle, 1988, Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome, Am J Obstet Gynecol, 158, 1459, 10.1016\u002F0002-9378(88)90382-1\nPabuccu, 1997, Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility, Fertil Steril, 68, 1141, 10.1016\u002FS0015-0282(97)00375-0\nMcComb, 1997, Simplified therapy for Asherman's syndrome, Fertil Steril, 68, 1047, 10.1016\u002FS0015-0282(97)00413-5\nBroome, 1999, Fluoroscopically guided hysteroscopic division of adhesions in severe Asherman syndrome, Obstet Gynecol, 93, 1041\nFeng, 1999, Diagnostic and therapeutic hysteroscopy for traumatic intrauterine adhesions after induced abortions: clinical analysis of 365 cases, Gynaecol Endosc, 8, 95, 10.1046\u002Fj.1365-2508.1999.00245.x\nCapella-Allouc, 1999, Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility, Hum Reprod, 14, 1230, 10.1093\u002Fhumrep\u002F14.5.1230\nJansen, 2000, Complications of hysteroscopy: a prospective, multicenter study, Obstet Gynecol, 96, 266\nPreutthipan, 2000, Reproductive outcome following hysteroscopic lysis of intrauterine adhesions: a result of 65 cases at Ramathibodi Hospital, J Med Assoc Thai, 83, 42\nPace, 2003, Endoscopic treatment of intrauterine adhesions, Clin Exp Obstet Gynecol, 30, 26\nZikopoulos, 2004, Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system, Reprod Biomed Online, 8, 720, 10.1016\u002FS1472-6483(10)61654-9\nFernandez, 2006, Fertility after treatment of Asherman's syndrome stage 3 and 4, J Minim Invasive Gynecol, 13, 398, 10.1016\u002Fj.jmig.2006.04.013\nRobinson, 2008, Postoperative adhesiolysis therapy for intrauterine adhesions (Asherman's syndrome), Fertil Steril, 90, 409, 10.1016\u002Fj.fertnstert.2007.06.034\nYu, 2008, Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome, Fertil Steril, 89, 715, 10.1016\u002Fj.fertnstert.2007.03.070\nWorldwide AAMIG, 2010, AAGL practice report: practice guidelines for management of intrauterine synechiae, J Minim Invasive Gynecol, 17, 1, 10.1016\u002Fj.jmig.2009.10.009\nPistofidis, 1996, Comparison of operative and fertility outcome between groups of women with intrauterine adhesions after adhesiolysis, J Am Assoc Gynecol Laparosc, 3, S40, 10.1016\u002FS1074-3804(96)80272-6\nRoge, 1996, Hysteroscopic management of uterine synechiae: a series of 102 observations, Eur J Obstet Gynecol Reprod Biol, 65, 189, 10.1016\u002F0301-2115(95)02342-9\nBougie, 2015, Treatment of Asherman's syndrome in an outpatient hysteroscopy setting, J Minim Invasive Gynecol, 22, 446, 10.1016\u002Fj.jmig.2014.12.006\nBukulmez, 1999, Total corporal synechiae due to tuberculosis carry a very poor prognosis following hysteroscopic synechialysis, Hum Reprod, 14, 1960, 10.1093\u002Fhumrep\u002F14.8.1960\nNappi, 2013, A multicenter, double-blind, randomized, placebo-controlled study to assess whether antibiotic administration should be recommended during office operative hysteroscopy, Reprod Sci, 20, 755, 10.1177\u002F1933719112466308\nRoy, 2014, Effectiveness of estrogen in the prevention of intrauterine adhesions after hysteroscopic septal resection: a prospective, randomized study, J Obstet Gynaecol Res, 40, 1085, 10.1111\u002Fjog.12297\nBosteels, 2015, Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility, Cochrane Database Syst Rev, CD011110\nRenier, 2005, Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration, Biomaterials, 26, 5368, 10.1016\u002Fj.biomaterials.2005.01.053\nJohary, 2014, Efficacy of estrogen therapy in patients with intrauterine adhesions: systematic review, J Minim Invasive Gynecol, 21, 44, 10.1016\u002Fj.jmig.2013.07.018\nWood, 1964, Treatment of traumatic uterine synechias, Int J Fertil, 9, 405\nAcunzo, 2003, Effectiveness of auto-cross-linked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic adhesiolysis: a prospective, randomized, controlled study, Hum Reprod, 18, 1918, 10.1093\u002Fhumrep\u002Fdeg368\nSantamaria, 2016, Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study, Hum Reprod, 31, 1087, 10.1093\u002Fhumrep\u002Fdew042",{"ES":1315},"Sinequias uterinas",{"VOID":1317},"10.1016\u002Fs1283-081x(17)86884-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X17868843",[1320,1345],{"id":1321,"sortIndex":115,"researcher":26,"roles":1322,"affiliations":1323,"properties":1342},"9018999b-30b6-4d44-a005-e68dcfb45f1b",[696],[1324,1332],{"id":26,"sortIndex":36,"affiliation":1325,"properties":26},{"id":1326,"createTime":1327,"updateTime":1327,"relativeEntities":1328,"slug":26,"properties":1329,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"15959a05-95fe-4266-a1c5-13d23e3cf303","2023-12-12T16:41:49.329+00:00",[],{"title":1330},{"VI":1331},"Service de gynécologie-obstétrique, hôpital Lariboisière, AP–HP, 2, rue Ambroise-Paré, 75010 Paris, France",{"id":1333,"sortIndex":115,"affiliation":1334,"properties":1341},"cd37c9d4-1b8d-4e2d-8672-a177a52ff2fe",{"id":1335,"createTime":1336,"updateTime":1336,"relativeEntities":1337,"slug":26,"properties":1338,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8c985c68-d1f7-4c49-9e87-37800bbf9071","2024-01-16T20:43:55.084+00:00",[],{"title":1339},{"VI":1340},"Université Paris-Diderot-Paris VII, Paris, France",{},{"title":1343},{"VI":1344},"J.-L. Benifla",{"id":1346,"sortIndex":36,"researcher":26,"roles":1347,"affiliations":1348,"properties":1361},"e14ab4fa-8979-423e-abc1-063e77535002",[696],[1349,1356],{"id":1350,"sortIndex":115,"affiliation":1351,"properties":1355},"bf2cf1f8-b76d-4301-afe4-52c87418d365",{"id":1335,"createTime":1336,"updateTime":1336,"relativeEntities":1352,"slug":26,"properties":1353,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1354},{"VI":1340},{},{"id":26,"sortIndex":36,"affiliation":1357,"properties":26},{"id":1326,"createTime":1327,"updateTime":1327,"relativeEntities":1358,"slug":26,"properties":1359,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1360},{"VI":1331},{"title":1362},{"VI":1363},"J. Sroussi",{"url":1318,"publisher":1365,"properties":1373},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1366,"slug":662,"properties":1367,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1370,"manageAffiliations":1371,"indexDatabases":1372,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1368,"title":1369},{"VOID":665},{"EN":667},[],[],[],{"volume":1374,"pages":1375},{"VOID":1197},{"VOID":1376},"1-14","2017-12-01",{"id":1379,"createTime":1380,"updateTime":1381,"relativeEntities":1382,"slug":1383,"properties":1384,"entityType":688,"verifyStatus":25,"verifyTime":1381,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1391,"fullTextUrl":26,"authors":1392,"publicationType":747,"publisherRelationship":1408,"citationCount":26,"citationInfo":26,"publishDate":1422,"publishYear":1423,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"dd1e0a89-b961-4079-b542-0bd7b4a1267d","2023-12-22T02:43:48.784+00:00","2025-02-27T00:59:40.992+00:00",[],"Estudio-del-electrocardiograma-fetal",{"references":1385,"title":1387,"doi":1389},{"VOID":1386},"Amer-Wahlin, 2001, Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum monitoring: a Swedish randomised controlled trial, Lancet, 358, 534, 10.1016\u002FS0140-6736(01)05703-8\nGreene, 1987, The ECG waveform, Baillères Clin Obstet Gynaecol, 1, 131, 10.1016\u002FS0950-3552(87)80027-5\nGreene, 1994, The ST waveform, 388\nJenkins, 1986, Can fetal electrocardiography improve the prediction of intrapartum fetal acidosis?, Br J Obstet Gynaecol, 93, 6, 10.1111\u002Fj.1471-0528.1986.tb07804.x\nKeunen, 2000, The PR interval-fetal heart rate relationship during repetitive umbilical cord occlusions in immature fetal sheep, Eur J Obstet Gynecol Reprod Biol, 89, 69, 10.1016\u002FS0301-2115(99)00160-8\nLilja, 1985, ST waveform changes of the fetal electrocardiogram during labour: a clinical entity, Br J Obstet Gynaecol, 92, 611, 10.1111\u002Fj.1471-0528.1985.tb01400.x\nNoren, 2003, Fetal electrocardiography in labor and neonatal outcome: data from the Swedish Randomized Controlled Trial on intrapartum fetal monitoring, Am J Obstet Gynecol, 188, 183, 10.1067\u002Fmob.2003.109\nReed, 1996, The potential impact of PR interval analysis of the fetal electrocardiogram (FECG) on intrapartum fetal monitoring, Eur J Obstet Gynecol Reprod Biol, 68, 87, 10.1016\u002F0301-2115(96)02496-7\nRosen, 1992, Clinical validity of fetal ECG waveform analysis, 95\nSkillern, 1994, A comparative study of the fetal electrocardiogram recorded by the STAN and Nottingham systems, Br J Obstet Gynaecol, 101, 582, 10.1111\u002Fj.1471-0528.1994.tb13647.x\nStrachan, 2000, Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial, Lancet, 355, 456, 10.1016\u002FS0140-6736(99)04373-1\nSymonds, 1994, The P wave and the PR interval, 381\nVan Wijngaarden, 2000, Improving intrapartum surveillance: an individualised T\u002FQRS ratio?, Eur J Obstet Gynecol Reprod Biol, 88, 43, 10.1016\u002FS0301-2115(99)00119-0\nVayssière, 2002, Surveillance de l'ECG foetal pendant le travail, 37\nWestgate, 1992, Randomized trial of cardiotocogram alone or with ST analysis for intrapartum monitoring, Lancet, 340, 194, 10.1016\u002F0140-6736(92)90465-F\nWhittle, 2000, Is it time to abandon cardiotocographic analysis?, Lancet, 355, 422, 10.1016\u002FS0140-6736(00)82002-4",{"ES":1388},"Estudio del electrocardiograma fetal",{"VOID":1390},"10.1016\u002Fs1283-081x(04)70228-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X04702283",[1393],{"id":1394,"sortIndex":36,"researcher":26,"roles":1395,"affiliations":1396,"properties":1405},"ac7c0576-5f9e-4a2d-9724-a8540bc8e6f0",[696],[1397],{"id":26,"sortIndex":36,"affiliation":1398,"properties":26},{"id":1399,"createTime":1400,"updateTime":1400,"relativeEntities":1401,"slug":26,"properties":1402,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"40a82849-6e47-48ae-b89d-4c0c769af739","2023-12-22T02:43:48.826+00:00",[],{"title":1403},{"VI":1404},"Service de gynécologie–obstétrique, Centre hospitalo-universitaire, 4, rue Larrey, 49033 Angers cedex 01, France",{"title":1406},{"VI":1407},"A. Fournié",{"url":1391,"publisher":1409,"properties":1417},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1410,"slug":662,"properties":1411,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1414,"manageAffiliations":1415,"indexDatabases":1416,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1412,"title":1413},{"VOID":665},{"EN":667},[],[],[],{"volume":1418,"pages":1420},{"VOID":1419},"40",{"VOID":1421},"1-3","2004-01-01",2004]